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FOREWORD 
 Studies detailed in this dissertation have been carried out in Dr. Oliver J. 
Rando’s lab in Biochemistry and Molecular Pharmacology Department at 
UMASS Medical School. This dissertation consists of 4 chapters and chapter II 
has been published in a peer-review journal and chapter III is in preparation for 
submission. I have a separate acknowledgement section at the end of the forth 
chapter to acknowledge my collaborators and their respective contributions for 
each chapter in detail. 
Foremost, I would like to express my deep gratitude to my advisor Dr. 
Oliver J Rando for his continued encouragement, motivation and support. He 
shared with me a lot of his expertise, research insights and critical thinking. I 
would also like to thank the members of my committee, Dr. Craig Peterson, Dr. 
Job Dekker, Dr. Paul Kaufman, Dr. Anthony Imbalzano and my chair, Dr. Alonzo 
Ross. I would like to extend my gratitude to all the past and present members of 
the Rando lab for creating a productive and friendly work environment. In 
particular, I would like to thank Dr. Marta Radman-Livaja not only for being 
collegial and excellent scientist but also for being a wonderful friend and great 
support. I cannot find enough words to thank Dr. Christopher J Lengner apart 
from being an excellent mentor and great collaborator; he has also been a dear 
friend for me. I also would like to thank Faculty in UMASS Medical School, 
particularly Dr. Thomas Fazzio, who has shared with me a lot of his expertise 
during our collaboration. 
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Also, I would like to thank my greatest support and dearest friend Dr. 
Ozlem Topaloglu and Hande Goksal, I am here because of your endless support. 
Finally, to all my friends from several different places, as Alfred L Tennyson tells 
in his poem “I am a part of all that I have met”, thank you for the support and 
enrichment you brought into my life. 
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ABSTRACT 
Different cell types in multi-cellular organisms heritably maintain different 
gene expression patterns despite carrying the same genome; a phenomenon 
termed epigenetics. It is widely believed that the packaging state of the genome, 
known as chromatin structure, carries epigenetic information. 
How chromatin states are inherited and how chromatin structure changes during 
development, moreover how different epigenomes, such as chromatin and DNA 
modifications communicate with each other during these processes are important 
questions. Accordingly, understanding the mechanisms that govern pluripotency 
and differentiation requires details of chromatin dynamics. The major goal of my 
doctoral thesis was to understand the genome wide view of chromatin dynamics 
in embryonic stem cells. 
My studies centered on two aspects of chromatin dynamics in mouse 
embryonic stem cells– localization and function of two antagonistic chromatin 
regulators and genome-wide histone variant dynamics. 
In the first part, we examined the roles of several chromatin regulators 
whose loss affects the pluripotent state of ES cells. We found that two such 
regulators, Mbd3 and Brg1, control a large number of genes in ES cells via 
antagonistic effects on promoter nucleosome occupancy. Moreover, we found 
that both Mbd3 and Brg1 play key roles in the biology of 5-hydroxymethylcytosine 
(5hmC), a newly identified DNA modification. Mbd3, which was named by 
homology to known cytosine methyl binding domains, yet does not bind 
methylcytosine in vitro, co-localized in ES cells with 5hmC. Furthermore, Mbd3 
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localization was lost in knockdown cells lacking the major 5mC hydroxylase, 
Tet1. Our results suggest, contrary to current dogma, that 5hmC is more than 
just an intermediate in cytosine demethylation pathways, that it may regulate 
genes via the Mbd3/NuRD complex. Finally, we showed that both Mbd3 and 
Brg1 are themselves required for normal levels of 5hmC in vivo, identifying a 
feedback loop between 5hmC and Mbd3. Together, our results identified a 
possible effector for 5hmC, thereby suggesting a functional role for this DNA 
modification. Moreover, Brg1 and Mbd3 can now be added to the growing list of 
regulators with opposite effects on ES cell gene expression, suggesting that pairs 
of antagonistic chromatin binding proteins may be a common phenomenon in ES 
cell transcription regulation (Yildirim et al., Cell 2011). 
The second part of my dissertation concerns the dynamics of several 
histone variants. Seminal studies in the Henikoff lab showed that certain histone 
variants are replaced throughout the cell cycle, in contrast to the predominant 
replication-coupled mode of histone assembly. Work in yeast and flies showed 
that rapid histone turnover occurs at epigenetically-regulated genomic regions, 
such as chromatin boundary elements or Polycomb/Trithorax binding sites. 
Notably, promoter regions of actively transcribed genes exhibit rapid turnover, 
suggesting that histone turnover may have an important role in gene regulation, 
as higher histone turnover rate would provide higher probability of DNA element 
exposure and faster erasure of chromatin marks of the replaced histones. In 
order to extend such studies to a model for pluripotency and differentiation, we 
developed a system for measuring histone replacement in mouse ES cells. To be 
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able to carry out turnover experiments in ES cells, we generated stable ES cell 
lines that can be induced to express epitope-tagged histone variants. Our results 
confirmed that histone turnover patterns are conserved from yeast to mammals 
and that turnover profiles are histone variant specific. Murine H3.3 turnover is 
similar to H3.3 turnover in flies, with peaks at the promoters of highly transcribed 
genes. MacroH2A2, a variant generally linked to gene repression, had a more 
complex turnover profile. Surprisingly, we found rapid exchange of macroH2A2 
occurring around transcription start sites of a number of highly expressed genes. 
At poorly expressed genes, on the other hand, macroH2A2 localizes upstream or 
downstream of transcription start sites and is incorporated slowly, either via slow 
turnover or via replication-coupled incorporation. Finally, we have used those 
inducible ES cell lines to generate mice, which will enable future studies on 
tissue-specific histone replacement in vivo. 
In summary, my thesis work not only significantly extends our 
understanding of chromatin regulation in general but also provides a more 
detailed landscape of chromatin structure and regulation in ES cells. Extending 
these analyses to differentiating cells and in vivo tissue specific dynamics should 
provide us with a better understanding not only of cell type specific chromatin 
organization but also improve our ability to program and re-program genomic 
landscapes in vitro. 
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CHAPTER 1 
 
Introduction 
 13
 DNA in eukaryotic cells is organized into chromatin through the packaging 
of highly conserved basic proteins called histone proteins. Four different histone 
proteins organize in an octomeric structure; an H3-H4 tetrameric particle in 
association with two H2A-H2B pairs wraps approximately 147 bp of DNA duplex 
(Figure1-1) (Luger et al., 1997b) and thereby forms the fundamental unit of 
chromatin called the nucleosome, first described by Kornberg in 1974 (Kornberg, 
1974; Kornberg and Thomas, 1974). Nucleosome core particles and the 
unwrapped connector DNA have been visualized as a “beads on a string” 
structure with electron microscopy (Olins and Olins, 1974). The linker DNA 
between nucleosome particles may be associated with the linker histone H1 
(Marino-Ramirez et al., 2005; Maxson et al., 1983). These packed nucleosome 
arrays in association with linker histones and other chromatin proteins allow the 
higher order organization of chromatin in the nucleus. Both the histone content of 
nucleosomes and post translational modifications of these histones as well as 
nucleosome positioning dictate the overall organization of chromatin; which is 
important for transcription, replication and other DNA-templated processes. 
HISTONE GENE REGULATION 
In contrast to the majority of eukaryotic genes, which are mostly 
expressed outside of S phase, the bulk of the core histone protein synthesis 
starts at the transition from G1 to S phase and peaks simultaneously with DNA 
replication, although they are expressed at low levels throughout the cell cycle 
(Maxson et al., 1983; Osley, 1991). In addition to the coordinated induction of 
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core histone synthesis, the increase in stability of histone mRNA is also an 
important factor in response to higher histone demand during replication. The 
inhibition of DNA replication halts histone synthesis and triggers rapid 
degradation of histone mRNA (Heintz et al., 1983). Moreover, excess histones 
that are not bound by chaperones or incorporated into chromatin are marked for 
degradation by Rad53 protein kinase and rapidly degraded in S.cerevisiae 
(Gunjan and Verreault, 2003). The stoichiometric balance between histone 
protein content and DNA is very important and therefore, tightly regulated, as 
nonspecific binding of basic histone proteins to DNA results in insoluble 
aggregates at physiological ionic strength (Gunjan et al., 2006). Accordingly, 
gene expression patterns and other mechanisms regulating histone levels in cells 
are highly conserved (Cho et al., 1998; Cho et al., 2001; Gunjan et al., 2006). 
Histone synthesis is regulated at several levels, and each organism seems to 
use different sets of regulatory mechanisms for histone homeostasis (Hentschel 
and Birnstiel, 1981). It can be regulated at the protein level- through factors that 
play a role in histone protein storage such as histone chaperones- or at 
transcriptional and posttranscriptional levels through the regulation of mRNA 
stability and pre-mRNA processing. Unlike the bulk of Pol II transcribed genes in 
metazoans, the canonical histone genes do not contain introns and they 
terminate their transcription with a highly conserved 3’-stem loop structure 
instead of a poly-A sequence (Osley, 1991). This highly conserved stem loop 
structure at the 3’end provides an excellent platform for orchestrated synthesis 
through the regulation of stem loop binding protein (SLBP) (Whitfield et al., 
 15
2000), which is proven to be a crucial protein for histone mRNA processing, 
translation and degradation (Marzluff et al., 2008). In spite of the similarities in 
histone proteins and their expression profiles, the transcriptional regulatory 
mechanisms vary across species (Marino-Ramirez et al., 2006). In all eukaryotes 
canonical core histone genes and in vertebrates, linker histones as well, are 
members of multi gene families. In some organisms, histone genes are 
organized in several tandem repeats spanning five histone genes, while in 
others, they are mostly dispersed with some clustering (Chaboute et al., 1993; 
Maxson et al., 1983). Coordinated histone assembly into nucleosomes and DNA 
synthesis during replication require co-expression of histone genes, which 
implies mechanisms for transcriptional co-regulation and common features of 
regulatory elements among different canonical histone genes in an organism. In 
addition to histone type specific regulatory motifs, the existence of such shared 
motifs between different histone types has also been demonstrated (Chowdhary 
et al., 2005; Isogai et al., 2007). 
HISTONE MODIFICATIONS 
All four nucleosomal histone proteins contain a histone fold domain that 
shares a common structure and an N-terminal histone tail of variable length 
(Arents and Moudrianakis, 1995). While the histone fold domain is globular, 
histone tails are unstructured, mostly protruding out from the nucleosome core 
particle. Histone proteins are subject to a large number of post translational 
modifications, especially the residues on amino terminal tails and some on the 
globular domain, and carboxy terminal tails as well, in the case of H2A and H2B. 
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These post translational modifications may introduce architectural changes that 
influence chromatin structure and consequently the regulation of the underlined 
DNA sequence, as evidenced by the enrichment of different modifications 
patterns over distinct chromatin domains. Some of the most common 
modifications are phosphorylation of serine and threonine residues; as well as 
acetylation or methylation of arginine and lysine residues, in addition to 
sumoylation or ubiquitylation of select lysine residues on some histone types. 
These covalent modifications may either influence the nucleosome structure itself 
by affecting DNA-histone and histone-histone interactions in the core particle or 
they may have an influence on higher order chromatin structure by affecting 
histone-histone interactions between neighboring nucleosomes. Moreover, they 
may provide docking sites for some proteins while they occlude others, thereby 
defining distinct chromatin domains. Many chromatin proteins and protein 
complexes are enriched for a number of structural domains that recognize 
specific modifications. Histone lysine acetylation is recognized by Bromodomain 
containing proteins. Histone lysine methylation is recognized by the royal family 
modules which include Chromodomain, Tudor, PWWP, MBT and nonrelated 
PHD domains. The WD-40 repeat, protein domain that is found in many 
chromatin associated proteins, is another module implicated in methyl-lysine 
binding (Kouzarides, 2007; Yap and Zhou, 2006).  
Genome wide mapping of single nucleosome histone modifications 
showed that histone modifications generally occur in broad domains, and they 
are mostly homogeneous (Liu et al., 2005) with few exceptions such as sharply 
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localized peaks of H3K4 mono-methylation along with H3K27 acetylation marking 
the cell type specific functional enhancers (Heintzman et al., 2009). The 5’ ends 
of gene bodies in transcriptionally active genes are highly enriched for H3K4 di-, 
tri-methylation, while H3K9 and H3K14 acetylation marks diffuse throughout the 
gene body. Two-nucleosome hypoacetylation events correspond to 5’ regions of 
repressed genes whereas large domains of acetylation depletion are 
characteristic of heterochromatic regions in yeast (Liu et al., 2005). While there 
are some special acetylation events, such as H3 lysine56 (H3K56) in the histone 
fold domain, which has been shown to be important for efficient replication 
dependent nucleosome assembly (Li et al., 2008) and H4K16 acetylation that 
plays a role in boundary maintenance and prevention of spreading of silencing by 
Sir proteins (Suka et al., 2002); hyper acetylation of histones is almost always 
associated with transcriptional activation. It has been shown that acetylation of 
lysine residues neutralizes its positive charge thereby reduces histone-DNA 
contacts, thus creates a more open chromatin structure , thought to be favorable 
for transcription (Dion et al., 2005; Shogren-Knaak et al., 2006). Conversely, the 
removal of acetylation consistently associates with repression of transcription. 
Enzymes that reverse the activity of histone acetyltransferases (HATs), are 
called histone deacetylases (HDACs), and these two opposing enzymes are 
members of activating and repressive chromatin complexes, respectively 
(Narlikar et al., 2002). Both HATs and HDACs do not show much substrate 
specificity especially when compared to lysine methyl transferases that usually 
modifies a single lysine residue on a specific histone protein. While some of 
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these methylations, namely on H3K4, H3K36 and H3K79 correlate with 
transcriptional activity; others particularly H3K9, H3K27 and H4K20 methylations 
are implicated in transcriptional repression (Barski et al., 2007). Unlike 
acetylation, ionic interactions are not affected by methylation. Instead, 
methylated residues provide a binding platform for recruitment of proteins with 
different methyl binding domains. For example H3K4 tri-methylation at actively 
transcribed genes recruits the chromatin remodeler CHD1 through its double 
chromo domain which in return facilitates transcription (Gaspar-Maia et al., 2009) 
although this mechanism does not apply in yeast (Sims et al., 2005). The core 
transcriptional machinery can also be recruited to H3K4me3 sites through the 
affinity of general transcription factor TFIID subunit TAF3 (van Ingen et al., 2008). 
In yeast, H3K36 tri-methylation deposited behind Pol II recruits the Rpd3S 
complex to transcribed gene bodies, which suppresses the cryptic transcription 
initiation events (Carrozza et al., 2005). Members of the enzyme family that 
methylate arginine residues are called protein arginine methyl transferases 
(PRMTs). Like lysine methylation, arginine methylation may associate with either 
transcriptional activation or repression. There are two specific residues known to 
be ubiquitinylated: one associated with repression and the other with activation, 
H2AK119 and H2BK120, respectively. A role for histone phosphorylation has 
been suggested in mitosis, apoptosis and gametogenesis, but histone 
phosphorylation links to gene expression are not clear. The best known histone 
phosphorylation event that has been implicated in transcriptional regulation is 
H3S10 phosphorylation, which recruits chromatin phospho binding protein and 
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plays a role in NF-kB mediated gene activation (Kouzarides, 2007). (Figure1-2 & 
Figure1-3 summarize some of the well known post translational histone 
modifications and their modifying enzymes)  
HISTONE VARIANTS 
Another factor that alters nucleosome structure and greatly influences 
chromatin domain definition is the replacement of canonical histones with 
structurally distinct variant histones; even though differences in the primary 
sequence may be as little as 4-5 amino acids. While canonical histones mostly 
play a role in monotonous genome packing, variant histones specialize in a 
range of tasks including chromosome segregation, DNA repair, dosage 
compensation and germ cell packaging.  
Unlike the replication dependent, canonical histones, which have an 
unusual gene organization, variant histone genes have the regular Pol II gene 
structure with introns and polyA tails. In addition, rather than being in histone 
gene clusters as their canonical counterparts, they are dispersed throughout the 
genome as single copy genes. Histone variants are expressed throughout the 
cell cycle and incorporated when and where they are needed through the 
guidance of specific histone chaperones. Phylogenetic analysis of histone 
proteins demonstrated that canonical histone proteins are one of the most 
evolutionarily conserved eukaryotic proteins (Malik and Henikoff, 2003). Among 
them, H4 histone is exceptionally conserved. While all other core histone proteins 
have non-allelic variants and/or replication independent versions with special 
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roles, H4 remains the same with hardly any sequence changes among 
eukaryotic kingdoms (Malik and Henikoff, 2003). All 26 H4 genes, both in mouse 
and human, encode exactly the same protein. Accordingly, there are no 
sequence variations between replication coupled and replication independent H4. 
Replication independent synthesis of invariant H4 and H2B histones are 
achieved by alternative post-transcriptional processing (Marzluff et al., 2002). In 
the octameric nucleosome core particle H3 aligns with H2A and H4 with H2B. It 
was suggested that this pair wise structural alignment may be the reason why 
both H3 and H2A enriched in different versions but not H4 and H2B (Henikoff 
and Ahmad, 2005). 
H2A VARIANTS 
H2A is the core histone with the largest number of variants. While H2Ax 
and H2Az are present in most eukaryotes, both H2A.Bbd and macroH2A are 
vertebrate specific H2A variants (Marino-Ramirez et al., 2005) (Figure1.4). H2Ax 
does not differ much from the canonical H2A aside from an additional C-terminal 
domain which is crucial for its specific function. Although the mechanism of its 
incorporation to its target domains is not known very well, it is phosphorylated on 
Ser139 residue of this conserved C terminal motif in response to DNA damage 
(Rogakou et al., 1998). A recent study demonstrated that the histone chaperone 
FACT is responsible for both its incorporation into and dissociation from the 
nucleosome in human cells. They showed that the phosphorylation of H2Ax by 
DNA protein kinases facilitates FACT mediated incorporation while PARylation of 
the FACT subunit Spt16 by PARP1 prevents its disassembly (Heo et al., 2008).  
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H2Ax phosphorylation quickly spreads around the double strand break sites and 
plays an important role in the formation of repair foci to which many components 
of the DNA damage repair machinery are recruited (Fernandez-Capetillo et al., 
2004). Independent from its role in genomic stability H2Ax is also crucial for 
sperm maturation and male fertility due to its role in meiotic sex chromosome 
inactivation and sex chromosome segregation (Celeste et al., 2002; Fernandez-
Capetillo et al., 2003). Furthermore, H2Ax phosphorylation through GABA 
receptor signaling plays role in S-phase cell cycle control in ES cells, which lack 
the G1-S cell cycle check point, and regulates embryonic stem cell and neural 
progenitor cell proliferation (Andang et al., 2008).   
Although the structures of H2Az and H2A containing nucleosomes are 
nearly identical (Suto et al., 2000), H2Az is nevertheless indispensible for many 
organisms. In mammals, H2Az is encoded by an essential gene and 
homozygous deletion in mice halts development at the peri-implantation stage 
(Faast et al., 2001). Similarly, in Drosophila, it has been shown to be imperative 
for development beyond larval stages (Clarkson et al., 1999). According to 
biochemical and structural analysis, H2Az stabilizes protein interactions within 
the same nucleosome and contributes to more stably folded nucleosome 
particles (Park et al., 2004) while it prevents chromatin condensation by impeding 
internucleosomal interactions akin to N-terminal histone acetylation (Fan et al., 
2002). Its exclusive localization to the transcriptionally active macronucleus in 
tetrahymena (Stargell et al., 1993) and a positive correlation with transcriptional 
activity in human cells (Barski et al., 2007; Jin et al., 2009) implicated it in 
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maintenance of transcriptionally competent chromatin. Besides, it was 
demonstrated that in human cells RNA Pol II recruitment is potentiated by H2Az 
enrichment at paused and active promoters, while it’s enriched in the body of 
non-transcribed genes (Hardy et al., 2009). In budding yeast Htz, the yeast 
orthologue of H2Az, is enriched at the boundary regions that prevent spreading 
of heterochromatin into euchromatic regions (Meneghini et al., 2003) where 
hyper dynamic H3 turnover is observed and suggested to contribute to the 
prevention of heterochromatin spreading (Dion et al., 2007). In contrast with its 
function in anti-silencing at heterochromatin boundaries, in S. pombe, H2Az 
works in concert with heterochromatin factors and RNAi machinery to suppress 
anti-sense RNA (Zofall et al., 2009). On the other hand, Htz assembles in the 
nucleosomes flanking nucleosome free regions (NFR) and marks both active and 
inactive genes in euchromatin (Raisner et al., 2005). Similarly, in human cells, 
transcriptionally active loci are marked with H2Az around the transcription start 
sites (TSSs) in association with H3.3, a histone variant that is also associated 
with transcriptional activity. Enrichment for this hybrid nucleosome core particle 
was also observed at other active regulatory regions (Jin et al., 2009). In addition 
to its involvement in gene activation there is also evidence linking H2Az to gene 
repression.. In embryonic stem cells, H2Az was found to be co-localized with 
polycomb group (PcG) protein Suz12 at developmental regulatory genes that are 
suppressed in the pluripotent state. And this co-localization at target promoters is 
interdependent as depletion of one reduced the enrichment of the other. 
Furthermore, depletion of H2Az leads to activation of these genes, underscoring 
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its role in repression (Creyghton et al., 2008). Another strong support for its role 
in gene inactivation was the demonstration of the role of the extended acidic 
patch of H2Az in recruitment of silencing protein HP1α which in return promotes 
higher order chromatin formation (Fan et al., 2004). In any case, it is not yet clear 
how H2Az positively or negatively influence transcription. 
Another H2A variant, H2ABbd is one of the most diverged versions of 
H2A. It has 48% primary sequence similarity to canonical H2A; it lacks the typical 
C-terminus tail and has a truncated docking domain, which tethers the H2A-H2B 
dimer to the H3-H4 tetramer (Malik and Henikoff, 2003). Therefore, these 
relatively short H2A variant containing nucleosomes only wrap 130bp of DNA 
(Doyen et al., 2006b). It was first recognized by its exclusion from the inactive X 
(Xi) chromosome in female mammalian cells and co-localization with H4K12Ac, 
which is indicative of euchromatin function (Chadwick and Willard, 2001b). 
Reconstitution studies suggested that H2ABbd-containing nucleosomes are 
looser and less stable than conventional H2A-containing nucleosomes. In vivo 
support to these studies came from FRAP experiments, showing that the 
fluorescence recovery of H2ABbd was faster than that of H2A (Gautier et al., 
2004). Nevertheless, H2ABbd containing nucleosomes are shown to be resistant 
to SWI/SNF remodeling. Unlike macroH2A containing nucleosomes, H2ABbd 
nucleosomes cannot be remodeled by either SWI/SNF or ACT even when 
remodeling is facilitated by the histone chaperone nucleolin (Angelov et al., 
2006).  This resistance to remodeling is due to the differences in the histone fold 
domain (Doyen et al., 2006b). Although it is found to be expressed in different 
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female tissues, a recent study demonstrated its presence in advance mouse 
spermiogenesis and mature human sperm.  And it is suggested that H2ABbd 
may facilitate histone displacement by protamins during sperm maturation 
(Ishibashi et al., 2010), although it is also conceivable that it may be important for 
the function of nucleosomaly organized regions during and after fertilization. 
Like H2A.Bbd, macroH2A is a vertebrate specific H2A variant (Marino-
Ramirez et al., 2005). H2A variants exhibit the most pronounced primary 
structure heterogeneity in their C-terminal domain. MacroH2A (also known as 
H2AFY) has a very distinct C-terminal domain that includes a small stretch of 
basic amino acids and a putative leucine zipper motif. While the N-terminal 
domain of the protein shares 65% amino acid sequence similarity with the 
canonical H2A, the C-terminal domain (also known as the macro domain) is 
almost twice as big as the canonical H2A and has no relation to other histones 
(Chadwick and Willard, 2001a). Interestingly, the C-terminal tail of H2A variants 
has the potential to interfere with H1 binding (Suto et al., 2000). The crystal 
structure of the macroH2A containing nucleosome core particle suggests that 
some of the structural differences, when compared to the canonical nucleosome 
structure, render it potentially more stable and less flexible (Chakravarthy et al., 
2005a). Biochemical analysis, showing high ionic strength and resistance to 
dissociation in lower salt concentrations (Abbott et al., 2005), further strengthens 
that notion. 
Despite being localized on different chromosomes- macroH2A1 on 13 and 
macroH2A2 (also known as H2AFY2) on 10- the two genes share a similar gene 
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structure with conserved exon-intron boundaries except for a spliced variant site 
in macroH2A1. MacroH2A1 encodes two spliced variants, macroH2A1.1 or 
macroH2A1.2 and both are conserved in mammals. MacroH2A2 is 80% identical 
to macroH2A1.2 and it is 98% conserved between mice and human (Chadwick 
and Willard, 2001a; Costanzi and Pehrson, 2001; Zhang et al., 2005). Even 
though they are preferentially expressed at different levels in different cell types 
in the same tissue, the two proteins seem to localize to the same genomic 
targets. MacroH2A1.1 differs from the other two forms in several ways, the 
functional consequences of which are presently not clear. In contrast to the splice 
variant macroH2a1.1, both macroH2a1.2 and macroH2a2 co-localize to inactive 
X chromosomes (Xi) in a distinct chromatin structure named the macro chromatin 
body (MCB) (Costanzi and Pehrson, 1998). They are also found in centrosomes 
(Chadwick and Willard, 2002) and senescence associated foci (Zhang et al., 
2005). Interestingly, MacroH2A1.1 expression was shown be restricted to 
terminally differentiated cells (Pehrson et al., 1997) and anti correlated with 
proliferation markers (Sporn et al., 2009). Additionally, macroH2A1.1 is the only 
form that can bind to the SirT-1 metabolite, O-acetyl-ADP-ribose (AAR) 
(Kustatscher et al., 2005) and the PARP1 metabolite PAR (poly ADP-ribose) 
(Timinszky et al., 2009). The interaction of the macro domain of macroH2A1.2 
with PARP1, although possibly non-specific (Timinszky et al., 2009), inhibits 
PARP1 enzymatic activity (Nusinow et al., 2007). 
MacroH2A enrichment of the Xi chromosome in female mammalian cells 
was interpreted as an evidence for its role in silencing (Costanzi and Pehrson, 
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1998), even though the association of macroH2a with the Xi appears to occur 
after random inactivation of the additional X chromosome (Chadwick and Willard, 
2001a). Moreover, macroH2a localization to Xi depends on the non coding RNA 
XIST but it is not required for the inactive state. When XIST is conditionally 
deleted, gene silencing is maintained despite the loss of macroH2a on Xi 
(Csankovszki et al., 1999).  
More evidence for its role in transcriptional repression stems from in vitro 
findings. The C-terminal ‘macro’ domain of macroH2A1.2 was shown to repress 
transcriptional initiation by almost 10 fold, mostly by preventing p300 HAT activity 
and chromatin remodeling (Doyen et al., 2006a). Additionally, another study 
demonstrated that macroH2A incorporation into nucleosome prevents the binding 
of the transcription factor NF-kB to nucleosomal DNA, while also it renders the 
nucleosome resistant to the SWI/SNF and ACF remodeling (Angelov et al., 
2003). Later, the same group demonstrated that the nuclear protein nucleolin, a 
FACT like histone chaperone that has a role in transcriptional activation, 
promotes the SWI/SNF remodeling of macroH2A containing nucleosomes 
(Angelov et al., 2006).  
As evidenced by its localization to autosomes, macroH2a’s functions go 
beyond its role in MCB formation in Xi. Additionally, organisms, such as chicken, 
that do not undergo X inactivation, still express this H2A variant (Abbott et al., 
2005). ChIP-Chip experiments demonstrated the co-localization of macroH2A1.2 
and macroH2A2 with the polycomb repressive complex 2 (PRC2) at 
developmentally regulated genes in the testicular cancer cell line NT2. 
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Consistent with its suggested role in gene repression, macroH2A occupancy was 
reduced upon induction of some of its target genes. Furthermore, when 
macroH2A levels were reduced by RNAi, transcriptional activation of these genes 
was stronger (Buschbeck et al., 2009).  Moreover, the Kraus group showed that 
macroH2A1 occupies large domains in autosomal chromosomes and mostly 
associates with transcriptional repression. In the positively regulated subset of its 
target genes, macroH2A was localized to coding regions. Interestingly, those 
positively regulated genes are involved in signal mediated transcription such as 
serum starvation, and RNAi depletion of macroH2A causes the loss of the serum 
starvation response, suggesting a direct role for macroH2A in transcriptional 
activation of these genes (Gamble et al., 2010). Similar results were found in 
mouse embryonic stem cells. During the retinoic acid induced neuronal 
differentiation of ES cells, transcriptional activation of retinoic acid targets and 
some other differentiation related genes depends on macroH2A1.2 occupancy of 
these genes. On the other hand, repression of core pluripotency factors upon 
induction of the differentiation program was less efficient in the absence of 
macroH2A1.2. Therefore, authors propose a role for macroH2A in maintaining 
the balance between self-renewal and differentiation of both adult and embryonic 
stem cells (Creppe et al., 2012). 
Meanwhile, several recent studies implicated macroH2A in human 
disease. In one study macroH2A expression was shown to be positively 
correlated with a good prognosis of lung cancer due to the strong negative 
correlation between tumor cell proliferation and macroH2A protein levels (Sporn 
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et al., 2009), while in another study, RNAi depletion of macroH2a in dormant 
melanoma cells was shown to render them metastatic (Kapoor et al., 2010). 
Additionally, macroH2A mislocalization through ATRX deficiency has been 
proposed to contribute to the alpha-thalassemia phenotype of the ATRX 
syndrome (Ratnakumar et al., 2012). Elevated expression of macroH2A1 in 
Huntington Disease (HD) is another example of histone dysregulation in human 
disease. The mouse model for HD confirmed the progressive up-regulation of 
macroH2A1 expression with disease progression. Even though there isn’t a 
suggested mechanistic role for macroH2A1 in HD pathology both the prognosis 
and macroH2A1 levels are responsive to HDAC inhibitor treatment (Hu et al., 
2011). Interestingly, the C-terminal non histone region (macro domain) was 
shown to bind HDAC1 and 2 (Chakravarthy et al., 2005a).  
HISTONE H3 VARIANTS 
In addition to two versions of replication dependent H3 core histones H3.1 
and H3.2, there are three replication independent H3 variants: a centromere 
specific H3 CenH3, a sperm specific H3t (Witt et al., 1996) and H3.3, which is 
expressed throughout the cell cycle and maintained during differentiation (Ahmad 
and Henikoff, 2002; Wu and Gilbert, 1981) (Figure1.5).  
CenH3 is a centromere specific H3 variant with 50 to 60% similarity to the 
canonical H3 in the histone fold domain and no sequence similarity in the N-
terminal tail which can be highly variable across different species (Malik and 
Henikoff, 2003). CenH3 is another essential histone variant and the homozygous 
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deletion of CenpA, the mammalian centromere specific H3, in mice causes post-
implantation lethality (Howman et al., 2000). Centromeres are chromosomal 
domains that anchor kinetechores, which attach mitotic spindle fibers and allow 
faithful chromosome segregation. Kinetechore formation at centromeres depends 
on a special chromatin structure and especially the presence of CenH3  (Collins 
et al., 2005). It has been suggested that it is centromere specific histones, rather 
than their underlying DNA sequences, that specify centromeres, since they are a 
more constant feature of centromers as opposed to the highly variable satellite 
DNA sequences found in those regions (Henikoff et al., 2004). Besides, human 
neocentromeres that are devoid of satellite DNA sequences can still assemble 
into centromeric structure. Furthermore, mislocalized CenH3 is subject to 
ubiquitin mediated rapid degradation (Collins et al., 2004). This high fidelity of 
CenH3 in annotating and maintaining specific chromatin domain have histone 
variants considered as prime candidates for carriers of epigenetic memory 
(Henikoff et al., 2004).  
H3.3 is another highly conserved H3 variant whose expression is not 
restricted to S phase. In human, mouse and flies H3.3 is expressed from 2 
separate genes, H3.3A and H3.3B. Both genes encode the exact same protein 
sequence from mRNA sequences with distinct promoter elements (Frank et al., 
2003) and un-translated regions (Bramlage et al., 1997), suggesting differential 
transcriptional and post-transcriptional regulation. H3.3 is associated with 
transcriptionally active genes and active regulatory elements (Ahmad and 
Henikoff, 2002; Goldberg et al., 2010), and has been involved in transcriptional 
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elongation and the replacement of nucleosomes evicted by the transcriptional 
machinery (Wirbelauer et al., 2005). In line with these findings, H3.3 is more 
enriched for transcriptional activity associated chromatin marks (Hake et al., 
2006; McKittrick et al., 2004; Sutcliffe et al., 2009). Its association with 
transcriptional activation is further supported by the observation that H3.3 
nucleosomes are depleted of heterochromatin binding protein1 (HP1) (Loyola et 
al., 2006) and they are refractory to linker histone H1 (Braunschweig et al., 
2009). In addition, another role for its involvement in transcriptional activation is 
indicated by the high H3.3 turnover rates at active regulatory elements as this 
hyper dynamic histone exchange possibly contributes to the accessibility of 
underlying DNA elements by transcription factors (Henikoff, 2008). Furthermore, 
the interference with canonical H3 incorporation in the early mouse embryo by 
depletion of subunits of the replication coupled chromatin assembly pathway 
results in increased H3.3 incorporation and consequently impaired 
heterochromatin formation (Akiyama et al., 2011). Surprisingly, H3.3 was shown 
to be enriched in the telomeric heterochromatin of murine ES cells and this 
enrichment correlates with normal telomere function and integrity (Goldberg et 
al., 2010; Lewis et al., 2010). H3.3 may replace H3.1 in a neutral way as well, in 
non-proliferating terminally differentiated cells after mitotic exit (Pina and Suau, 
1987) and during DNA repair outside of S phase (Zhang et al., 2007) where H3.3 
compensate for H3.1 to maintain consistent nucleosome density. Hence, there 
appear to be two different mechanisms for H3.3 assembly into nucleosomes, one 
for processes that replace canonical H3 outside of S phase and the other for 
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producing functionally distinct transcriptionally permissive chromatin domains. 
The distinct distribution of H3.3 in the genome (Drane et al., 2010; Goldberg et 
al., 2010; Mito et al., 2005) and its importance for certain cell types (Orsi et al., 
2009; Sakai et al., 2009; Torres-Padilla et al., 2007) strongly suggest  that H3.3 
is more than just a surrogate for H3.1 and emphasizes its crucial role in  normal 
chromatin regulation. However, H3.3 deletion in drosophila has been shown to 
be viable and its depletion was compensated by up-regulation of canonical H3 
genes. While H3.3 depletion is tolerable in terms of viability it was indispensible 
for fertility as homozygous mutants were invariably sterile (Sakai et al., 2009), 
suggesting a role for H3.3 in transitioning from nucleosomal chromatin to 
protamins during sperm maturation or during chromatin reorganization at 
fertilization. In agreement with this idea, the H3.3 specific chaperone HIRA 
(Bonnefoy et al., 2005; Loppin et al., 2005) and the chromatin remodeler CHD1 
(Konev et al., 2007) are critical for paternal chromatin rearrangement during 
fertilization and early embryo development. Male fertility was also found to be 
severely compromised in mice with H3.3 defects; H3.3A gene disruption not only 
resulted in reduced fertility but also caused partial neonatal lethality in 
homozygous mutants (Couldrey et al., 1999), despite existence of an intact 
H3.3B gene which produces the same protein product. In mammals, 
nucleosomes evicted during chromatin reorganization in meiotic sex 
chromosome inactivation (MSCI) and silencing of unsynapsed autosomal 
chromatin (MSUC) are replaced exclusively with H3.3 containing nucleosomes. 
The authors of the study argue that such nucleosome turnover and incorporation 
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of newly synthesized H3.3 provide a blank slate for the redecoration of 
nucleosomes with specific histone modifications necessary for normal chromatin 
formation in the germ line (van der Heijden et al., 2007).  
HISTONE CHAPERONES & CHROMATIN REMODELERS 
The preferential incorporation of histone variants with distinct functions to 
specific chromatin domains in eukaryotic genomes suggests that there are 
specialized deposition mechanisms for targeting of histone variants to particular 
loci. How different histone variants are targeted to specific chromatin domains 
and what are the structural and functional consequences of variant incorporation 
to distinct loci are important questions. Several studies aimed to answer these 
questions and confirmed the role of different histone chaperones and chromatin 
remodelers in the differential localization of histone variants.  
Histone chaperones are defined as factors that associate with histones to 
escort them to their destination and facilitate their assembly into chromatin. It is 
suggested that the characteristic property of a histone chaperone is histone 
transfer but not necessarily the ability to function as a histone assembly factor 
(De Koning et al., 2007) (Table1.1). Histone chaperones play important roles in 
preventing nonspecific association of highly basic histone proteins with nucleic 
acids by binding free histones and escorting them to their deposition sites. 
Replication coupled histone deposition onto nascent DNA is governed by the 
three subunit protein called Chromatin Assembly Factor 1 (CAF-1). The 
canonical H3s- H3.1 and H3.2-associate with CAF-1 that travels behind the 
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replication fork with the proliferating cell nuclear antigen (PCNA) and they are 
incorporated into chromatin in a replication coupled manner (Shibahara and 
Stillman, 1999). While in yeast the sole H3 variant associates with both Caf1 and 
HirA, in vertebrate HIRA binds specifically to the replication independent H3 
variant H3.3 (Tagami et al., 2004). The amino acid substitutions in the histone 
fold domain in H3.3 allow this selective association with replication independent 
chromatin assembly factors (Ahmad and Henikoff, 2002). On the other hand,. 
both chaperones receive the newly synthesized H3-H4 dimers from the same 
histone chaperone Asf1 (Tagami et al., 2004), which also mediates transcription 
coupled eviction as well as deposition of H3-H4 dimers (Schwabish and Struhl, 
2006). Recent studies show that HIRA is not the only chaperone responsible for 
H3.3 deposition. In fact, various chaperones facilitate the differential targeting of 
H3.3 throughout mammalian chromatin. While HIRA is mostly involved in H3.3 
deposition at promoter regions of active genes and in transcription coupled 
deposition, the Daxx-Atrx complex is required for H3.3 localization at pericentric 
heterochromatin and telomeres (Drane et al., 2010; Lewis et al., 2010; Wong et 
al., 2010). DEK is another novel H3 chaperone which has been shown to have 
H3.3 specificity in vitro and is potentially responsible for H3.3 deposition at 
regulatory elements (Sawatsubashi et al., 2010).  
Because the eukaryotic genome is organized into chromatin, accessibility 
of  nucleosomal DNA, as well as regulation of DNA templated processes depend 
on the cooperation between several factors including sequence specific DNA 
binding proteins, histone and DNA modifications, histone variants, repressors, 
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activator and mediator complexes of the general transcriptional machinery 
working in coordination with chromatin regulatory factors such as histone 
modifying enzymes, histone chaperones and ATP dependent chromatin 
remodelers. All known chromatin remodelers contain an ATP hydrolyzing Snf2p-
related catalytic core which is homologous to the large helicase super family 
2(SF2) and they are usually part of a large protein complex such as the SWI/SNF 
chromatin remodeling complex (Flaus and Owen-Hughes, 2004). Like many 
Snf2p-related proteins, the SWI/SNF complex works directly on nucleosomes 
and unravels the octamer in association with histone chaperones (Clapier and 
Cairns, 2009; Cote et al., 1994). In vivo findings show that transcription through 
nucleosomes requires dimer displacement. Accordingly chromatin remodeling 
complexes at sites of RNA Pol2 activity were shown to be associated with the 
histone chaperone FACT (Belotserkovskaya et al., 2003). Biochemical analysis 
also implicated similar cooperation between the histone chaperone Nap1 and the 
ATP dependent chromatin remodeling factor RSC in vitro (Lorch et al., 2006). In 
addition, the chromatin remodeling machinery may re-position nucleosomes as a 
secondary result of DNA distortion they induced, since several ATP dependent 
chromatin remodelers are capable of DNA-translocation activity (Saha et al., 
2002).  
Remodeling enzymes are usually recruited to their target location by other 
regulatory proteins, such as sequence specific transcription factors, 
transcriptional co-activators and general transcription machinery components or 
by transcriptional repressors (Goldmark et al., 2000; Peterson and Workman, 
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2000). Another way of targeting involves direct binding to histone modifications or 
to histone tails through specific recognition domains, such as the recruitment  of 
SWI/SNF to specific acetylation patterns via the bromodomain of Snf2 protein 
(Hassan et al., 2002) or the recruitment of ISWI to histone tails or to linker 
histones through its SANT domain (Boyer et al., 2004). Likewise, the CHD family 
of remodelers can be recruited by methylated histone H3 tails through its tandem 
chromodomains (Flanagan et al., 2005). Like SWI/SNF, INO80 family utilizes its 
helicase-SANT-associated (HSA) domain which allows its association with actin 
related protein subunits (Szerlong et al., 2008) such as Arp4 and Arp8 that can 
bind to histones and may also have a histone chaperone function (Watanabe and 
Peterson, 2010). Therefore, chromatin remodeling complexes work in 
coordination with histone modifying enzymes and enable recruitment of 
transcriptional regulators to target loci (Cosma et al., 1999). Different subunit 
compositions within remodeling complexes define them both functionally and 
structurally and provide them with specialized functions. For instance, embryonic 
stem cell specific SWI/SNF-like remodeling complex, esBAF is characterized by 
several subunits which allow its functional role in pluripotency by co-occupaying 
and regulating the function of core pluripotency genes (Lessard and Crabtree, 
2010). In the mean time, different families of chromatin remodeling complexes 
are decorated for executing distinct tasks. While SWI/SNF complex activity 
usually disrupts initially equally spaced nucleosomal arrays to promote activation; 
the ISWI family plays a central role in nucleosome assembly and nucleosome 
positioning to produce ordered nucleosomal arrays, mostly to promote repression 
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(Goldmark et al., 2000).  However, there are examples of uncharacteristic activity 
for each family, such as SWI/SNF promoting repression by facilitating repressor 
binding (Martens and Winston, 2002) and ISWI assisting transcriptional 
elongation by organizing nucleosomal arrays in the gene body (Morillon et al., 
2003). The two members of the INO80 family, INO80 and SWR-C, also have 
distinct functions. While INO80 uses ATP hydrolysis to mobilize and relocate 
nucleosomes on DNA and has several functions including replication fork 
progression, transcriptional activation and DNA repair, SWR1 is incapable of 
DNA translocation reaction. On the other hand, it has a unique ability to catalyze 
dimer exchange; specifically replacing canonical H2A-H2B dimers with variant 
H2Az-H2B dimers in a unidirectional manner (Luk et al., 2010). A recent 
biochemical study in support with genome wide ChIP analysis showed that the 
INO80 complex can counteract SWR1 activity and specifically replace H2Az-H2B 
dimers with H2A-H2B. Accordingly, INO80 deletion causes abnormal spreading 
of H2Az as well as genome instability in yeast (Papamichos-Chronakis et al., 
2011; Watanabe and Peterson, 2010). The fourth chromatin remodeling family is 
the CHD family, characterized by two N-terminal tandem chromodomains and a 
SNF2 like ATPase domain. The CHD family has 9 different members with distinct 
functions. In mammals CHD1 is thought to be involved in transcriptional 
activation because of  its association with pre-initiation factors and has also been 
implicated in facilitating transcriptional elongation as well as splicing (Sims et al., 
2007). CHD3 and CHD4, also known as Mi-2α and Mi-2β, respectively, lack the 
DNA binding domain but harbor a PHD (Plant Homology Domain), which is an 
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alternative methyl lysine binding domain. CHD3/4 is the member of a large 
protein complex called NURD (nucleosome remodeling and deacetylation 
complex). HDAC1, HDAC2, MTA1, MTA2, MTA3, RbAp48, RbAp46, MBD2 or 
MBD3 are the other subunits of NURD. Although NURD could be classified as a 
repressor according to its subunit content, it is linked to both gene repression and 
activation (McDonel et al., 2009). The chromatin remodeling activity of NURD 
was suggested to facilitate access to acetylated nucleosomes as the HDAC 
activity of the complex was shown to be stimulated by ATP hydrolysis (Tong et 
al., 1998). A limited number of studies suggests that NURD may be recruited to 
its targets through transcription factors (Kim et al., 1999); although, it has also 
been shown that MBD2 containing NURD but not MBD3 containing NURD can 
be recruited to methylated DNA (Le Guezennec et al., 2006).  
DNA METHYLATION & HYDROXYMETHYLATION 
DNA methylation is another epigenetic modification that influences cell 
type specific gene expression profiles and enables the inheritance of these 
expression profiles during cell division. Three enzymes with DNA methyl 
transferase activity are responsible for the establishment and maintenance of 
mammalian DNA methylation patterns. In mammals, cytosines, that are followed 
by guanine (CpG dinucleotide), receive the methylation mark. Initial methylation 
patterns are established by two catalytically active de novo DNA methyl 
transferases Dnmt3a and Dnmt3b; and during imprinting in association with the 
catalytically inactive Dnmt3l (Hata et al., 2002). Maintenance of the existing DNA 
methylation patterns during replication is provided by the methyl transferase 
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Dnmt1 which interacts with PCNA in replication foci and preferentially methylates 
hemi-methylated CpG dinucleotides (Chuang et al., 1997). All three catalytically 
active DNA methylation enzymes are essential for viability as mice, deficient for 
those genes, are either embryonically lethal or post natal lethal (Wu and Zhang, 
2010). DNA methylation patterns, while relatively stable in somatic cells, are 
erased and reestablished in the zygote and the pre-implantation embryo 
respectively (Wu and Zhang, 2010). This “do over” of methylation patterns is 
critical for the establishment of pluripotency and normal development (Feng et 
al., 2010). It is therefore not surprising that abnormal DNA methylation patterns 
are frequent in tumor cells (Baylin and Jones, 2011). 
CpG dinucleotides are distributed disproportionately in mammalian 
genomes. Low density CpG dinucleotides are scattered throughout the genome 
and are mostly methylated. High GC content regions of approximately one 
thousand base pairs in size, with discrete CpG dinucleotide rich clusters are 
called CpG islands (CGIs). CGIs usually mark transcription initiation sites and are 
frequently not methylated in mammalian genomes except in the intergenic 
“orphan” CGIs in which CpG methylation is more frequent (Deaton and Bird, 
2011). CGI containing promoters include housekeeping genes, developmental 
regulators and tissue specific genes; covering around 70% of annotated 
promoters in vertebrate genomes (Saxonov et al., 2006). These promoters have 
a distinct chromatin structure and transcriptional regulation. The transcriptionally 
permissive nature of CGI promoters is demonstrated by genome wide 
transcriptome analysis both with RNA Pol II ChIP-Seq (Guenther et al., 2007) 
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and global nuclear run-on experiments (Core and Lis, 2008). In agreement with 
its transcriptionally permissive nature, CGI chromatin is suggested to be 
intrinsically accessible and does not require ATP dependent chromatin 
remodeling activity (Deaton and Bird, 2011). Accordingly, it is also enriched for 
transcriptional activity associated histone modifications such as hyperacetylation 
of H3 and H4, as well as the exclusion of linker histone H1 (Tazi and Bird, 1990). 
Moreover, genome wide studies revealed that H3K4me3 is a signature histone 
modification of CGI chromatin, independently of the promoter’s activity state in 
human and mouse cells (Guenther et al., 2007; Mikkelsen et al., 2008). Similarly, 
in mouse embryonic stem cells, unmethylated high density CpG dinucleotides 
are associated with housekeeping genes or developmentally important genes, 
while methylated low density CpG regions correspond to tissue specific gene 
promoters. CpG methylation levels and histone modifications are highly 
correlated: housekeeping genes with a high CpG dinucleotide content are highly 
expressed and enriched for the transcriptional activity associated histone 
modification H3K4me3. On the other hand developmentally regulated genes 
carry both the activation and repression associated histone modifications 
H3K4me3 and H3K27me3, respectively, and they are transcriptionally inactive 
(Meissner et al., 2008).  
Methylation of CGIs provides stable silencing of relevant genes during 
differentiation and is necessary for normal development (Mohn et al., 2008). 
Silencing via DNA methylation is thought to be either by inhibition of transcription 
factor binding due to methylated DNA itself or through the recruitment of methyl 
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binding domain proteins, which mediates the establishment of repressive 
chromatin (Deal et al., 2010; Klose and Bird, 2006). In line with this idea, all 
known interacting partners  of methyl binding domain (MBD) containing proteins 
are transcriptional repressors and their association with MBD family members 
further supports their silencing activity (Bogdanovic and Veenstra, 2009). 
However, as evident from the X chromosome inactivation, DNA methylation is a 
later event in silencing; it occurs after the establishment of repressive chromatin 
modifications such as histone hypoacetylation as well as transcriptional silencing. 
Rather than playing a role in the initiation of the silencing, DNA methylation 
provides the stability of silencing (Csankovszki et al., 2001). Hence, genomic 
regions in need of long term silencing such as imprinted genes, transposons and 
Xi tend to be methylated.  
Although DNA methylation is a faithfully heritable, stable epigenetic 
modification, there are occasions where demethylation occurs; either by passive 
dilution of methylation in the absence of Dnmt1 during replication or by an active 
enzymatic process. Existence of genome wide (for example the demethylation of 
the paternal genome during embryonic development) and gene specific DNA 
demethylation events suggested the existence of active DNA demethylation 
mechanisms. Several pathways were proposed for active DNA demethylation 
reaction including base excision repair after DNA glycolysation or deamination, 
as well as nucleotide excision mechanisms in coordination with the GADD45A 
DNA damage response function. These proposed mechanisms, however, fail to 
explain rapid genome wide demethylation activity (Wu and Zhang, 2010). On the 
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other hand oxidative demethylation mechanisms and TET (ten-eleven 
translocation) family proteins appear to be better candidates for global 
demethylation enzymes. Tet1, the first identified member of the Tet protein 
family, was shown to be responsible for the generation of 5-
hydroxymethylcytosine (5hmC) from 5meC both in vitro and vivo (Tahiliani et al., 
2009). Later, the other two members of the Tet family; Tet2 and Tet3 enzymes 
were also shown to be capable of hydrolyzing 5meC to 5hmC (Ito et al., 2010).  
Recent genome wide studies demonstrated that Tet1 localizes at CpG rich 
promoters along with Polycomb proteins (Wu et al., 2011c), suggesting that it is 
another factor that defines CGI chromatin in murine ES cells. On the other hand,   
5hmC is found both in promoter regions and gene bodies of ES cells (Wu et al., 
2011a). The signature histone modification H3K4me3, found at CGI promoters, is 
catalyzed by the MLL and SET1 protein families, which are both recruited to 
unmethylated CGI promoters by a CXXC domain, found in the proteins 
themselves or their interacting partners (Illingworth et al., 2008). Tet1, which also 
contains a CXXC domain, was proposed to be responsible for the depletion of 
methylation at CGIs by catalyzing the oxidation of 5meC to 5hmC (Wu et al., 
2012). In line with this idea, Tet1 depletion in ES cells leads to increased DNA 
methylation at many Tet1 target promoters (Williams et al., 2011; Wu et al., 
2011a). 
Despite the general idea that hydroxymethylation is primarily an 
intermediate stage in cytosine demethylation (Bhutani et al., 2011), the relatively 
persistent steady-state levels of 5hmC observed in several contexts (for 
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example, during global “demethylation” of paternal DNA after fertilization (Inoue 
and Zhang, 2011b; Iqbal et al., 2011) suggest otherwise. Its enrichment, 
especially in certain cell types such as purkinje neurons (Kriaucionis and Heintz, 
2009) and embryonic stem cells, suggests that hydroxymethylation may also 
serve as another DNA modification. It may facilitate the formation of distinct 
chromatin domains by recruiting or excluding certain factors and serve a specific 
regulatory function. In line with this idea, MBD family proteins, with intact methyl 
binding domains which allow their recruitment to methylated DNA, are incapable 
of binding hydroxymethylated DNA in vitro (Jin et al., 2010). While the Tet1 KO 
mice are viable and fertile (Dawlaty et al., 2011), Tet1 and Tet2 depletion in ES 
cells results in differentiation defects with abnormal activation of the extra-
embryonic gene expression program (Koh et al., 2011). Interestingly, depletion of 
the Mbd3 protein- which cannot bind methylated DNA (Hendrich and Bird, 1998) 
in ES cells leads to similar defects as the ones observed in Tet1 KD in ES cells, 
exhibiting increased expression of some trophectoderm markers (Kaji et al., 
2006) (Zhu et al., 2009). 
PLURIPOTENT CHROMATIN & EPIGENETIC MEMORY 
The zygote and the early blastomeres until the 8 cell stage have the 
greatest lineage potential called totipotency, which indicates the ability to 
generate both embryonic and extra-embryonic lineages. By the time that the 
embryo reaches the 16 cell stage, the first differentiation event occurs when 
totipotent blastomeres give rise to either outer cells or inner cells of the late 
morula stage, precursor cells of extra-embryonic (trophectoderm) or embryonic 
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lineages (inner cell mass), respectively (Surani et al., 2007). Embryonic stem 
(ES) cells are derived from the inner cell mass (ICM) of pre-implantation embryo. 
ES cells (ICM in vivo) have two characteristic features: pluripotency and self 
renewal. The first defines their potential to adopt different cellular programs and 
give rise to all the cells of the three primary germ layers of the embryo. The 
second describes their capacity to inherit this permissive state through an 
unlimited number of apparently symmetrical divisions without differentiating 
(Loebel et al., 2003; Meissner et al., 2009; Nishikawa et al., 2007). Moreover, 
they may be induced to acquire new transcription programs in vitro that are 
reminiscent of the developmental programs in vivo and differentiate into specified 
cells while they gradually lose their developmental potential and permissive state 
for alternative fates. Therefore, they are an ideal model for studying chromatin 
regulation and its role in mammalian development as well as epigenetic 
mechanisms involved in genomic and cellular plasticity.  
One of the most curious questions about an ES cell is “what makes an ES 
cell capable of assuming any cellular type in the organism?” Recently, many 
studies aimed to answer this question by focusing on ES cell specific 
transcriptional networks (Boyer et al., 2005; Wang et al., 2006). Data obtained 
from those studies identified proteins that control chromatin structure and 
accessibility. These findings not only emphasize the role of epigenetic 
mechanisms in the maintenance of cell type specific transcription programs, but 
also suggest their relevance in the maintenance of pluripotency. Accordingly, 
genetic ablation of factors ranging from Polycomb to the TIP60 complex to 
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components of the NURD complex and others have all been shown to have 
defects in either the maintenance of the pluripotent state, or defects in 
differentiation (Boyer et al., 2006; Creyghton et al., 2008; Fazzio et al., 2008b; 
Kaji et al., 2006).  
Pluripotent chromatin is transcriptionally more permissive and this open 
chromatin structure is actively maintained by chromatin remodeling factors, as 
the depletion of Chd1 in ES cells leads to the increase in heterochromatic foci 
and features that associate with it including HP1 and H3K9me3 (Gaspar-Maia et 
al., 2009). Besides, undifferentiated ES cells express considerably higher 
amounts of general transcription factors and chromatin remodelers; when 
compared to neural precursor cells (Efroni et al., 2008). Furthermore, microscopy 
studies revealed distinct features of heterochromatin in pluripotency. While larger 
and fewer domains of heterochromatic regions show a looser structure in ES 
cells, upon differentiation heterochromatin become condensed and more 
abundant (Meshorer and Misteli, 2006). The flexible arrangement of pluripotent 
chromatin has become more obvious in FRAP (Fluorescence Recovery after 
Photobleaching) experiments. In differentiated cells, the inner core of 
nucleosomes is known to be stable, while H2A-H2B dimers on the surface of the 
nucleosome exchange more readily (Kimura and Cook, 2001). Conversely, 
FRAP studies in ES cells showed that inner core histones have a “hyperdynamic” 
nature. Their high fluorescence recovery suggests a high histone turnover rate 
(Meshorer et al., 2006). Compellingly, fluorescence recovery rates substantially 
decrease upon differentiation to neural precursor cells suggesting a role for 
 45
histone turnover in the maintenance of genomic plasticity. Correspondingly, ES 
cell chromatin is more enriched for transcriptional activity associated histone 
modifications (Efroni et al., 2008) and for the replacement histone H3.3 (Hake et 
al., 2006; McKittrick et al., 2004; Sutcliffe et al., 2009).  
The single cell zygote, gives rise to more than 200 different cell types in 
the mammalian body. In an organism, all these cell types essentially carry the 
same genome but still manage to establish and maintain their cellular identity. 
One of the major distinctions between differentiated cell types is that different 
populations of cells express specific subsets of their genome. Accordingly, 
establishment and maintenance of cellular identity depends on regulatory 
mechanisms that control specific transcriptional profiles, relevant for that 
particular cell type. Such specific transcriptional programs are maintained and 
established by specific gene activation and silencing processes when and where 
they are needed (Orlando, 2003). Moreover, these differential gene expression 
patterns are heritable and different in different types of cells with identical DNA 
sequence. Such maintenance of specific phenotypes by non-genetic means is 
called epigenetic inheritance. It has been suggested that much of the heritable 
epigenetic information is carried by chromatin structure. Nucleosomal positioning, 
protein composition of the histone octamer (with canonical or variant histones) 
and covalent modification states of the histone proteins shape chromatin 
structure and are therefore potential information carriers  (Henikoff et al., 2004; 
Rando, 2007). Accordingly, chromatin regulatory mechanisms are involved in the 
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maintenance and inheritance of cellular memory as well as genomic plasticity 
(Theise and Wilmut, 2003).  
Genetic screens in Drosophila for mutants with developmental defects 
identified Polycomb (PcG) and Trithorax (TrxG) group proteins as factors 
required for memory of differentiated states (Ringrose and Paro, 2007). These 
proteins were later shown to act as chromatin modifying proteins – Polycomb 
repressors and some members of Trithorax activators both chemically modify 
histone proteins and alter chromatin compaction, acting as central players in 
epigenetic programming (Boyer et al., 2006). Thus, the interplay between 
PcG/TrxG proteins and chromatin structure regulates the genome organization 
which affects gene expression and epigenetic inheritance. Recently, PcG/TrxG 
proteins have been implicated as key factors in the control of chromatin structure 
in embryonic stem cells (Ang et al., 2011; Boyer et al., 2006). In the pluripotent 
state, genes controlling developmental pathways, especially lineage specific 
transcription factors, are repressed by Polycomb group proteins and are 
preferentially de-repressed upon differentiation (Bracken et al., 2006; Lee et al., 
2006a). Interestingly, histone methylation patterns typical of both PcG and TrxG- 
repressive and active marks,  respectively- co-exist at promoters of 
developmentally important transcription factors in embryonic stem cells but not in 
their differentiated counterparts (Bernstein et al., 2006). Moreover, these so 
called ‘bivalent domains’; of the chromatin of genes that are poised for activation 
but kept repressed, resolve upon differentiation. Genes with bivalent domains get 
either activated and loose the repressive mark- methyl-H3K27- or become 
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permanently repressed and lose their active mark- methyl-H3K4 (Bernstein et al., 
2006). Thus, this contentious state of chromatin may have a role in ES cell 
plasticity by priming genes involved in developmental regulation and providing a 
flexible arrangement in pluripotent genome organization. Accordingly, bivalent 
genes are depleted of DNA methylation which provides more stable repression, 
while many of those become methylated and transcriptionally silenced upon 
induction of differentiation. Furthermore, depletion of de novo DNA methyl 
transferases compromises the ES cells differentiation potential but their self-
renewal properties (Trowbridge and Orkin, 2010), Conversely, the depletion of 
the maintenance DNA methyl transferase Dnmt1 leads to premature 
differentiation of progenitor cells and loss of self-renewal (Sen et al., 2010).  
Although tissue specific transcription factors play important roles in 
defining cellular identity, chromatin is essential for maintaining and stabilizing it. 
While a defined set of transcription factors is sufficient to reprogram differentiated 
cells into an embryonic stem cell state (Takahashi and Yamanaka, 2006; Wernig 
et al., 2007) or to another differentiated cell state (Zhou et al., 2008), 
reprogrammed cells show preference to re-differentiate into their original cell type 
(Hu et al., 2010) and they may carry residual DNA methylation signatures of their 
tissue of origin (Kim et al., 2010b; Kim et al., 2011). This suggests that erasing 
epigenetic memory and resetting chromatin is not easy to accomplish.  Moreover, 
chromatin factors are essential not only for experimental reprogramming but also 
for natural reprogramming during zygotic genome activation and primordial germ 
cell (PGC) development. Chromatin regulators such as DOT1L, Suv39h1 (Onder 
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et al., 2012), and Brg1 (Singhal et al., 2010) affects the efficiency and kinetics of 
cell reprogramming while, Brg1 (Bultman et al., 2006) is essential for switching 
from the zygotic to the embryonic program, and Nap1 mediated histone 
replacement is important for the erasure of epigenetic memory during PGC 
reprogramming (Hajkova et al., 2008). These findings indicate that chromatin 
factors play roles in both maintenance and disruption of epigenetic states and 
successive transmission of these differential expression profiles through several 
generations relies on epigenetic memory. Accordingly, a more in depth 
knowledge of chromatin dynamics and chromatin regulatory mechanisms is 
required for a better understanding of the mechanisms that govern pluripotency 
and differentiation.  
Therefore I focused on different aspects of pluripotent chromatin not only 
to have a better insight in chromatin dynamics and epigenetic mechanisms that 
are involved in regulation of stemness but also to understand the details of this 
permissive chromatin organization. In chapter two we explore the details of 
interactions between different chromatin remodeling factors with respect to DNA 
modifications and their interacting partners. While in chapter three, we focused 
on the histone turnover phenomenon and present genome wide organization and 
dynamics of different histone variants both in embryonic stem cells and their 
committed counterparts. 
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Figure 1-1 
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Figure 1-1. Packaging of eukaryotic DNA into chromatin 
A) Front view of nucleosome core particle (protein data base 1AOI) (Luger et 
al., 1997a). H3, H4, H2A and H2B are shown in pink, blue, green and orange 
respectively. Histone octamer, containing a pair of each histone proteins, is 
wrapped by approximately 147 base pairs of DNA in 1.67 superhelical turns. 
Unstructured histone tails are viewed protruding from the core particle. 
B) Side view of the same structure obtained by 90º rotation 
C) Adapted from Chakravarthy S. et al., (Chakravarthy et al., 2005b) DNA in 
eukaryotes organized into chromatin via the histone protein complex, 
nucleosome core particle. Internucleosomal interactions provides moderate to 
high levels of nucleosomal array folding, while highly folded nucleosomal arrays’ 
long range interactions allows higher order chromatin fiber organization. 
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Figure 1-2 
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Figure 1-2. Histone H3 modifications and modifying enzymes. 
A large number of histone posttranslational modifications occur at histone H3 N-
terminal tails but there are specific sites that are modified within the globular 
histone core such as H3K56, H3Y41 and H3K79; acetylated, phosphorylated and 
methylated respectively. Numerous lysine residues are acetylated in H3 tails 
including, H3K9, H3K14, H3K18 and H3K36. While all known H3 acetylation 
marks associate with transcriptional activation, lysine and arginine methylation 
can either associate with activation as in the cases of H3K4me3 and H3R17me 
or be involved in repression as in the cases of H3K27me3, H3K9me3 and 
H3R2me. 
(Phosphorylation, acetylation and methylation events shown by yellow circles 
marked with P, blue circles marked with ac and red circles marked with me 
respectively. Enzymes responsible from the modification of specific residues are 
mentioned in the boxes with corresponding colors.) 
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Figure 1-3 
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Figure 1-3. Histone H2A, H2B and H4 modifications and modifying enzymes. 
H2A/H4S1 phosphorylation is enhanced in mitotic chromatin during chromatin 
condensation. Two ubiquitylation events one in H2AK119 and the other in 
H2B120 associate with repression and activation respectively. H2AK119 is 
ubiquitylated by Bmi/Ring1A , a protein found in the polycomb complex. H2B is 
ubiquitylated by RNF20/RNF40 and UbcH6 in humans and promotes facilitate 
transcriptional elongation. Two specific methylation events occur in H4 tails. 
While H4R3 methylation associates with hyperacetylation via recruitment of p300 
and transcriptional activation, H3K20 methylation plays a role in the formation 
and maintenance of heterochromatin as well as DNA repair. 
(Phosphorylation, acetylation, methylation and ubiquitylation events shown by 
yellow circles marked with P, blue circles marked with ac, red circles marked with 
me and purple circles marked with ub respectively. Enzymes responsible for the 
modification of specific residues are mentioned in the boxes with corresponding 
colors.) 
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Figure 1-4 
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Figure 1-4. Vertebrate Histone H2A variants. 
Histone H2A is the most diverse histone type, while H2Ax and H2Az are 
universal H2A variants, present in most eukaryotes, macroH2A and H2ABbd are 
vertebrate specific. H2Ax has a similar histone fold domain to canonical H2A but 
has a signature consensus sequence (SQEY) at its C-terminal which gets 
phosphorylated at S139 residue upon DNA damage (star signifies the 
phosphorylation event). The essential H2A variant H2Az is highly conserved 
between species (95% conservation between mammalian and urchin), and it is 
59% conserved between mammalian H2Az and H2A1 (Hatch and Bonner, 1988). 
The acidic patch in canonical H2A (DEE) extended by one residue (to DEELD); 
this extended acidic patch (signified with pink patch on histone fold domain) has 
been shown to be important for its deposition and function in chromatin. H2ABbd 
is only 48% identical to canonical H2A and it is particularly divergent with its 
shorter docking domain. MacroH2A is almost 3 times bigger than canonical H2A 
due to its non histone macro domain and linker region. But its N-terminal third is 
64% identical to full length canonical H2A (Pehrson and Fried, 1992). 
MacroH2A1 has two spliced variants, MacroH2A1.1 and 1.2. MacroH2A2 is most 
similar to MacroH2A1.2 with 80% identical amino acid sequence except for the 
alternative splice site. Alternatively spliced exon 6 of MacroH2A1.1 is shown in 
pink in the macro domain. 
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Figure 1-5 
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Figure 1-5. Mammalian Histone H3 variants. 
There are two isotypes of replication dependent H3s; H3.1 and H3.2. These 
canonical H3s differ by one amino acid at their 96th residue cytosine/ serine 
respectively. Replication independent H3.3 and testis specific H3t only differs by 
5 amino acids (at different residues) from canonical H3.1. Whereas CENPA, 
mammalian centromeric histone H3, has only 60% identity at histone fold domain 
of canonical H3s and has no sequence similarity in N-terminal tail. 
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Histone Chaperones Histone Selectivity Main Functions 
Complex 
Association 
Asf1a & Asf1b H3.1-H4 & H3.3-H4 Histone donor  for  CAF-1 and HIRA 
 
tNasp & sNasp H3-H4 H3-H4 storage 
 
Spt6  H3-H4 Transcription initiation & elongation  
Daxx/Atrx H3.3-H4 
DNA synthesis independent 
deposition at pericentric 
heterochromatin & telomeres 
 
DEK H3.3-H4 DNA synthesis independent deposition at regulatory elements 
 
HJURP CENPA-H4 Centromeric chromatin formation  
Nucleophosmin (NPM1, 2 & 3) H2A-H2B 
Cytosolic-nuclear transport,  
replication, 
transcription 
 
Chz1 (Sc.); HIRIP3? (Hs) H2AZ-H2B H2AZ incorporation by SWR1  
Nap1 
Nap1related proteins:  
Nap1L2 (Mm),SET/TAF1b(Hs), 
CINAP (Hs, Mm) 
H2A-H2B 
Cytosolic-nuclear transport 
Transcription 
Replication 
 
Nucleolin (Hs, Ms) H2A-H2B Transcription elongation; assist chromatin remodeling 
 
 
CAF-1 
complex           
                        
p150 
H3.1-H4 
DNA synthesis dependent 
deposition: 
Replication & Repair 
 
p60 
RbAp48 
HIRA 
complex 
HIRA 
H3.3-H4 DNA synthesis independent deposition 
 
Ubinuclein 
Cabin1 
FACT 
complex  
Spt16 H2A-H2B 
Transcription elongation 
 
SSRP1 H3-H4 
Rsf-1  H3-H4 Assist remodeling complex  RSF 
Arp4 ND Assist remodeling complex & HAT   INO80, HAT Tip60  
Arp7, Arp9 ND Assist  remodeling complex 
  
SWI/SNF & RSC 
BAF/PBAF&BAP 
Arp8  H3-H4 Assist  remodeling complex  INO80 
Acf1  H2A-H2B & H3-H4 Assist  remodeling complex  ACF/CHRAC 
RbAp48 
H3.1-H4 DNA synthesis dependent deposition 
 
 
CAF-1 complex, 
Remodeling 
Complex, HAT, 
HDAC, PC 
H3.3-H4 DNA synthesis independent deposition 
CENPA-H4 Centromeric chromatin maintenance 
 
Table1-1 
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Table 1-1. Histone Chaperones and their main functions. 
Histone chaperones, their histone type specificity and main functions are 
summarized (Adapted from De Koning et al., 2007) (De Koning et al., 2007). 
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CHAPTER 2 
 
 
 
Mbd3/NURD complex regulates expression of 
5-hydroxymethylcytosine marked genes in embryonic stem cells 
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The following work is reprinted from the Cell article of the same name published 
as: 
Ozlem Yildirim1, Ruowang Li2, Jui-Hung Hung2, Poshen B. Chen3, Xianjun Dong2, Ly-
sha Ee3, Zhiping Weng1,2, Oliver J. Rando1† and Thomas G. Fazzio3,4† 
Cell, 23 December 2011: Vol. 147, Issue 7, pp. 1498–1510. 
 
 
 
ABSTRACT 
Numerous chromatin regulators are required for embryonic stem (ES) cell 
self-renewal and pluripotency, but few have been studied in detail. Here, we 
examine the roles of several chromatin regulators whose loss affects the 
pluripotent state of ES cells. We find that Mbd3 and Brg1 antagonistically 
regulate a common set of genes by regulating promoter nucleosome occupancy. 
Furthermore, both Mbd3 and Brg1 play key roles in the biology of 5-
hydroxymethylcytosine (5hmC): Mbd3 co-localizes with Tet1 and 5hmC in vivo, 
Mbd3 knockdown preferentially affects expression of 5hmC-marked genes, Mbd3 
localization is Tet1-dependent, and Mbd3 preferentially binds to 5hmC relative to 
5-methylcytosine in vitro. Finally, both Mbd3 and Brg1 are themselves required 
for normal levels of 5hmC in vivo. Together, our results identify an effector for 
5hmC, and reveal that control of gene expression by antagonistic chromatin 
regulators is a surprisingly common regulatory strategy in ES cells. 
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In human and mouse embryonic stem (ES) cells, a number of 
transcriptional regulators are essential to maintain the pluripotent state. Several 
transcription factors are required for pluripotency, including Oct4, Sox2 and 
Nanog, which function as "master regulators" of the ES cell transcriptional 
network (Young, 2011). Along with sequence-specific transcription factors, many 
chromatin regulators also play essential roles in ES cell gene regulation, self-
renewal, and differentiation. 
Brg1 and Mbd3 have opposing effects on expression of shared target 
genes 
To better understand chromatin regulation of the ES cell transcriptional 
regulatory network, we sought to identify the transcriptional targets and functional 
relationships among six chromatin regulators with important roles in ES cell self-
renewal and pluripotency: Tip60, p400, Suz12 (involved in H3K27 methylation), 
Ash2l (involved in H3K4 methylation), Mbd3 and Brg1. We measured genome-
wide mRNA changes upon knockdown (KD) of each factor alone or in all pair-
wise combinations (to identify synergistic or epistatic relationships) in murine ES 
cells (Table S2-1). Consistent with previous data (Fazzio et al., 2008b), KD of 
Tip60 or p400, alone or in combinations with other factors, exhibited similar 
changes in gene expression (Figures 2-1A, S2-1A), while Brg1 and Mbd3 KD 
profiles were poorly correlated with these gene expression effects. Principal 
component analysis (PCA) confirmed that KD of Tip60 or p400 elicited the 
strongest changes in gene expression (Figure 2-1B). 
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Surprisingly, Brg1 KD and Mbd3 KD affected the same principal 
component as one another but in opposite directions, suggesting that these two 
factors oppositely regulate expression of a common set of targets. Indeed, the 
overlap of genes misregulated upon Brg1 or Mbd3 KD was highly significant (p < 
2.2e-16). As genes that were similarly up- or down-regulated in both Mbd3 KD 
and Brg1 KD cells were also nonspecifically affected by other KDs (Figure S2-
1B), we therefore we focused on the large group of genes upregulated upon 
Mbd3 KD and downregulated upon Brg1 KD (Figure 2-1C). We validated several 
of these common Brg1/Mbd3 targets by quantitative RT-PCR (RTqPCR) (Figure 
S2-1C), and found that expression of these genes was also altered in 
independent Mbd3 or Brg1 KDs using non-overlapping esiRNAs (Figure S2-1D) 
and in KDs of additional subunits of either the Mbd3/NURD or BAF complexes 
(Figure S2-1E). We next searched for epistatic effects between Mbd3 and Brg1. 
Double KD of Brg1 and Mbd3 resulted in a more wild type mRNA profile than 
either single KD, indicating that these proteins play antagonistic roles at their 
common target genes (Figures 2-1C and S2-1C).  
What features do Mbd3/Brg1 target genes share in common? In normal 
ES cells, Mbd3/Brg1 target genes are expressed at moderate to high levels 
(Figure 2-1D). Shared targets between these complexes were enriched for a 
number of functional categories, several of which relate to cellular adhesion and 
signaling (Table S2-2). Among the common targets of Brg1 and Mbd3, we noted 
genes encoding signaling molecules with important functions in ES cell self-
renewal or differentiation, including Wnt3a and Tgfb1 (Figure S2-1C). These 
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findings suggest that Mbd3/NURD and BAF complexes function in opposition to 
fine-tune the expression of a set of genes required for ES cell viability or self-
renewal. 
Mbd3 binds just downstream of the TSS 
Are the joint Brg1/Mbd3-regulated genes direct targets of these 
complexes? While Brg1 has been mapped genome-wide in ES cells (Ho et al., 
2009a), Mbd3 localization is currently unknown. We therefore carried out ChIP-
Seq for Mbd3 in murine ES cells, finding that Mbd3 localized largely to promoters 
(Figures 2-2A-C, S2-2, S2-3A,B), with only weak localization to enhancers 
(Figures S2-4A,B). Genes upregulated upon Mbd3 KD were associated with 
somewhat higher levels of Mbd3 than were unaffected genes (Figure S2-3C), 
although, as is commonly observed with chromatin regulators (Fan et al., 2005; 
Jiang et al., 2011; Rando and Chang, 2009; Wu et al., 2011b; Wu et al., 2011c), 
only a small subset of Mbd3-bound loci are transcriptionally affected by Mbd3 
loss (Figure 2-2A). 
 Comparing Mbd3 maps to prior maps of Brg1 binding (Ho et al., 2009a), 
we found significant overlap between the binding sites of the two factors (Figure 
2-2B, S2-4C). We validated Brg1 and Mbd3 binding at several common target 
promoters in ES cells by qPCR (Figure S2-3B). Interestingly, Mbd3 binding 
typically occurred ~100-200 bp downstream of the average peak of Brg1 (Figure 
2-2C), suggesting that these complexes bind in an oriented fashion with respect 
to the direction of transcription (see below). Furthermore, both Mbd3 and Brg1 
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were significantly associated with their antagonistically-regulated target genes 
(Figure 2-2D, Figure S2-4D).  
 How are Brg1 and Mbd3 recruited to common promoters?  We first asked 
whether Brg1 and Mbd3 physically interact in vivo using IP-Westerns. 
Immunoprecipitation using anti-Mbd3 antibody, but not control IgG, co-
precipitated Brg1 (Figure 2-2E), indicating that these proteins interact in ES 
cells, as observed in K562 cells (Mahajan et al., 2005) and suggested by mass 
spectrometry of esBAF (Ho et al., 2009b). To further probe the functional 
relationship between Brg1 and Mbd3, we mapped Mbd3 genome-wide in Brg1 
KD ES cells (Figure 2-2F), finding that Mbd3 localization was lost upon Brg1 KD. 
Together, these results indicate that Brg1 and Mbd3 directly associate with and 
regulate a common set of target genes in ES cells. 
 
Mbd3 binding is enriched at bivalent genes 
We next compared Mbd3 binding to previously published ChIP-Seq 
datasets in murine ES cells. Figure 2-3A shows the difference in Mbd3 binding 
levels between genes bound by a particular factor and those unbound, as 
defined in (Kim et al., 2010a). Mbd3 binding was substantially higher at targets of 
the Polycomb proteins Ezh1, Suz12, Phc1, and Eed, as well as the histone 
modifications associated with most Polycomb targets in ES cells: H3K27me3 and 
H3K4me3 (Figures 2-3A-C). Furthermore, similar to Polycomb localization, 
Mbd3 localization was strongest at CpG-rich promoters and weakest at CpG-
poor promoters (Figure 2-3D). Finally, Mbd3 was localized to all four Hox 
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clusters, as previously observed for several PRC1 and PRC2 subunits (Boyer et 
al., 2006) (Figure S2-3A). 
 These data suggest that Mbd3 may function with Polycomb and/or 
MLL/SET1 complexes to regulate gene expression. Interestingly, we noted that 
the gene expression profile of Mbd3 KD ES cells strongly correlated with that of 
Suz12 KD ES cells, and to a lesser extent with that of Ash2l KD ES cells (Figure 
2-1A), indicating that both H3K4me3 and H3K27me3 affect many “bivalent” 
genes similarly, and that Mbd3 may also regulate these genes. Indeed, most 
genes significantly up- or down-regulated upon Mbd3 KD were changed in the 
same direction upon KD of either Suz12 or Ash2l (Figures 2-3E,F), although the 
effects of Suz12 or Ash2l on gene expression were generally less severe. Thus, 
Mbd3 is directly associated with a significant fraction of Polycomb-bound genes, 
and contributes to their repression. 
 To attempt to understand why only a subset of Mbd3-bound genes were 
affected transcriptionally by Mbd3 knockdown, we carried out a multivariate 
regression analysis (see Experimental Procedures). Linear combinations of 
genome-wide binding data for 38 factors or modifications were optimized to best 
explain the effects of Mbd3 KD on expression of Mbd3/Brg1 common targets 
(Figures S2-5A,B). The full model exhibited a high correlation (R = 0.40) 
between predicted and measured effects of Mbd3 KD on gene expression. The 
strongest predictors of Mbd3 effects on gene expression included Tet1 and 5-
hydroxymethylcytosine localization (see below). Beyond these, strong predictors 
of Mbd3 function included H3K27me3 (individual R=0.29), Mbd3 (R=0.13), and 
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transcription factors such as Esrrb, E2F1, and Klf4, whereas core pluripotency 
factors such as Oct4, Sox2, and Nanog contributed little (Figure S2-5B and data 
not shown). These data are consistent with proteomics studies showing that 
Esrrb physically associates with the BAF and Mbd3/NURD complexes (van den 
Berg et al., 2010), and suggest that genes regulated by this transcription factor 
are particularly sensitive to Mbd3 function. 
Opposing chromatin remodeling functions of Mbd3 and Brg1 regulate 
recruitment of RNA Polymerase II  
How do Mbd3 and Brg1 control gene expression at their common target 
genes? NURD complexes contain both a Swi2/Snf2-related ATPase (Mi-2) and a 
pair of histone deacetylase subunits (Hdac1 and Hdac2). We therefore analyzed 
nucleosome occupancy (measured by H3 abundance) and H4 acetylation at 
Mbd3/Brg1 targets by ChIP-qPCR. Genes repressed by Mbd3 exhibited 
decreased H3 occupancy and increased H4 acetylation upon Mbd3 KD (Figures 
2-4A,B), suggesting that the Mbd3 complex represses target genes by 
deacetylating and stabilizing nucleosomes at promoters. Conversely, Brg1 
knockdown resulted in variable effects on H4 acetylation, but consistent 
increases in H3 occupancy (Figures 2-4A,B). Thus, we find that Brg1 and Mbd3 
antagonistically control nucleosome occupancy at target genes, with Brg1-
mediated nucleosome loss associated with gene activation, and competing 
nucleosome stabilization and deacetylation by Mbd3 associated with gene 
repression. 
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How do these changes in chromatin architecture affect transcription? 
Many genes in eukaryotes are regulated by transcriptional pausing (Guertin et 
al., 2010). Given the localization of Mbd3 downstream of the TSS (Figure 2-2C), 
we considered the hypothesis that Mbd3 could play a role in enforcing a 
transcriptional pause. We therefore carried out whole-genome RNA Polymerase 
II (Pol II) mapping in EGFP KD, Mbd3 KD, and Brg1 KD ES cells. Overall, 
genome-wide Pol II localization was similar in all three KDs (Figure 2-4C), 
exhibiting in each case the expected promoter-proximal peaks corresponding to 
bidirectional transcription (Core et al., 2008; Seila et al., 2008). We next focused 
on the group of genes repressed by Mbd3 and activated by Brg1 (Figure 2-4D). 
If Mbd3 functioned solely to arrest Pol II, then mRNA increases in Mbd3 KD 
should be reflected in a loss of 5’ Pol II and an increase in downstream Pol II. 
Instead, we find that the 5’ peak of Pol II increases at these target genes in the 
Mbd3 KD, and decreases in the Brg1 KD, mirroring the effects of each KD on 
mRNA levels. Since the global Pol II profiles are nearly identical for all three KDs 
(Figure 2-4C), these data are consistent with a primary role for Mbd3 and Brg1 in 
regulating recruitment of Pol II specifically to target promoters, although an 
additional role in regulating Pol II pausing cannot be ruled out. 
Knockdown of Tet1 impairs Mbd3 recruitment to target genes 
Despite being named Methyl Binding Domain based on its homology to 
the methyl binding domain from MeCP2, mammalian Mbd3 does not appear to 
associate with cytosine-methylated DNA (Hendrich and Bird, 1998; Zhang et al., 
1999). Interestingly, we noted that one prominent phenotype of Mbd3 null or KD 
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ES cells — upregulation of genes involved in trophectoderm differentiation — 
shares similarities to that of ES cells depleted of Tet1 (Ito et al., 2010; Koh et al., 
2011), which converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine 
(5hmC). We therefore speculated that Mbd3 might be regulated by 5hmC, rather 
than 5mC. To test this hypothesis, we compared Mbd3 localization to maps of 
Tet1 in murine ES cells (Wu et al., 2011c). Similar to Tet1 localization, Mbd3 was 
found at CpG-rich promoters, and correlated with Polycomb localization patterns 
(Figures 2-3C-D). High levels of 5hmC accompany Mbd3-associated genes in 
ES cells (Wu et al., 2011a) (Figure 2-5A), and Mbd3 and Tet1 localization 
patterns exhibited strong overlap (Figure 2-5B). Furthermore, genes repressed 
by Mbd3 were associated with significantly higher levels of Tet1 and 5hmC than 
genes unaffected by Mbd3 KD (Figures S2-5B-C). 
We therefore asked whether cytosine hydroxymethylation functions in 
Mbd3 localization. Since, in ES cells, Tet1 KD significantly decreases 
hydroxymethylation levels, we carried out genome-wide mapping of Mbd3 in Tet1 
KD ES cells. Strikingly, Mbd3 was completely delocalized in Tet1 KD cells, 
despite normal levels of Mbd3 protein in this knockdown (Figures 2-5B-E). Thus, 
hydroxymethylation, or some other aspect of Tet1 function, is necessary for 
Mbd3 association with target genes. 
Mbd3 binds 5hmC- but not 5mC-containing DNA in vitro 
Our results suggest that hydroxymethylation is not solely an intermediate 
state in a cytosine demethylation pathway, but that it also plays a distinct role in 
gene regulation via Mbd3 recruitment. As Mbd3 does not specifically bind to 5mC 
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in vitro, we considered the hypothesis that it might instead bind to 5hmC. To test 
this, we purified Mbd3/NURD complex from ES cells (Figures 2-6A, S2-6A-B), 
finding that this complex contained low levels of Tet1 (Figure 2-6B), identifying a 
direct physical link between Tet1 and Mbd3. 
 We carried out electrophoretic mobility shift assays (EMSAs) using probes 
with unmodified cytosine (C), 5mC, or 5hmC. As shown in Figure 2-6C, 
Mbd3/NURD complex had little effect on the methylated probe, but strongly 
shifted the 5hmC probe, whereas an untagged purification did not shift any of the 
probes (Figure S2-6C). Interestingly, Mbd3/NURD also shifted the unmodified 
“C” probe, but the shifted band was broader than the uniform shift of the 5hmC 
probe. These data suggest that Mbd3/NURD complex employs distinct modes of 
binding to unmodified and hydroxymethylated DNA. 
 To determine whether Mbd3/NURD’s specificity for 5hmC over 5mC was 
due to Mbd3, we tested recombinant Mbd3 for binding to the same probes. 
Consistent with the results obtained using the full complex, recombinant Mbd3 
exhibited strongest binding to hydroxymethylated DNA probes, with comparable 
but slightly reduced binding to unmodified probe, and dramatically lower binding 
to methylated probe (Figures 2-6D, S2-6D). As a control, recombinant methyl 
binding domain from Mbd1 specifically shifted the methylated probe (Figure 2-
6E), as expected (Hendrich and Bird, 1998; Ohki et al., 2001). Together, these 
data confirm the hypothesis that Mbd3 and Mbd3 complexes do not bind to DNA 
harboring 5mC, but can bind 5hmC-marked DNA in a manner qualitatively 
distinct from that of DNA containing unmodified cytosine. 
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Knockdown of Mbd3 or Brg1 affects global 5hmC levels 
Given the physical interaction between Mbd3 and Tet1, we next asked if 
Mbd3 affected 5hmC in vivo. Compared to control cells, Tet1 KD ES cells 
exhibited reduced 5hmC levels by dot blotting and thin layer chromatography 
(Figures 2-7A,C), as previously reported (Koh et al., 2011; Wu et al., 2011a) 
(Ficz et al., 2011a). To our surprise, both Mbd3 KD and Brg1 KD ES cells also 
exhibited strong reductions in global 5hmC levels as assayed by dot blotting 
(Figures 2-7A, S2-7). This effect of Mbd3 KD on bulk 5hmC levels was 
independently quantified by thin layer chromatography (Figures 2-7B,C). To 
extend these results to in vivo targets of Mbd3, we measured the enrichment of 
5hmC (Song et al., 2011) at several Mbd3 target genes. We observed similar 
losses of 5hmC at six loci in Tet1 KD and in Mbd3 KD cells (Figure 2-7D). 
Finally, we compared 5hmC staining of individual cells by immunofluorescence in 
control cells to cells depleted of Tet1, Mbd3, or Brg1. Consistent with the above 
results, we observed noticeably reduced 5hmC levels in most Tet1, Mbd3 and 
Brg1 KD cells compared to control (Figure 2-7E). Therefore, we conclude that 
Mbd3 and Brg1 function globally to establish or maintain normal levels of 5hmC 
in ES cells. 
DISCUSSION 
The epigenetic control of stem cell pluripotency and self-renewal has been 
subject to intense scrutiny in recent years.  Extensive attention has been given to 
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specific coactivators/corepressors such as Polycomb Repressive Complexes, 
whereas other important chromatin regulators have received less attention. Here, 
we focused on Brg1 and Mbd3, components of coactivator and corepressor 
complexes, the mechanisms by which they antagonistically regulate a group of 
common target genes, and their role in the biology of 5hmC. 
Antagonistic control of gene expression by BAF and Mbd3/NURD 
complexes 
Several hundred genes were antagonistically regulated by Brg1 and 
Mbd3, showing increased expression in Mbd3KD, decreased expression in 
Brg1KD, and wild type-like expression in double KDs. These results are of great 
interest in the context of the “bivalent” chromatin architecture seen in ES cells, in 
which the activation-associated histone mark H3K4me3 and the repression-
associated H3K27me3 mark co-occur at a large number of “master regulator” 
genes involved in cell fate decisions (Bernstein et al., 2006). However, reduction 
of H3K4me3 in ES cells by KD of Ash2l (Fazzio et al., 2008b) or Dpy-30 (Jiang et 
al., 2011) does not cause self-renewal defects, nor does H3K4me3 appear to be 
important for expression of most genes in ES cells (Jiang et al., 2011) (Table S2-
1). Indeed, our results with Ash2l and Suz12 knockdowns show that reduction of 
either H3K4me3 or H3K27me3 results, “paradoxically”, in similar effects on gene 
expression (Figures 2-3E,F). Conversely, we show here that Mbd3 and Brg1 
exhibit opposing functional effects on RNA Polymerase II recruitment and gene 
expression at several hundred genes. Together, these data suggest that the 
juxtaposition of opposing histone modifications or chromatin regulators near the 
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regulatory sequences of shared target genes is a common regulatory strategy in 
ES cells. 
Mbd3/NURD plays a central role in 5-hydroxymethylcytosine biology 
The inability of Mbd3 to bind specifically to 5mC (Hendrich and Bird, 1998; 
Zhang et al., 1999) raises the question of what function the “methyl binding 
domain” of this protein serves. We noted that ES cells depleted of Tet1, which 
catalyzes the hydroxylation of 5mC to form 5hmC, exhibit phenotypes similar to 
those of Mbd3 KD ES cells (Kaji et al., 2006; Koh et al., 2011; Zhu et al., 2009). 
Intriguingly, one of the few sequence differences in the methyl binding domain 
between human/mouse Mbd3 and remaining Mbd family members is a 
substitution of a phenylalanine for a tyrosine (numbered Y34/F34 in human 
Mbd1/Mbd3). This sequence change is largely responsible for Mbd3’s lack of 
5mC binding in vitro (Saito and Ishikawa, 2002). In the structure of Mbd1 bound 
to methylated DNA, Y34 is located immediately adjacent to the 5-methyl group of 
5mC (Ohki et al., 2001) (Figure S2-6E). Thus, loss of the hydroxyl group (Y34F) 
at this position in Mbd3 could almost perfectly compensate for the additional 
hydroxyl group in 5hmC relative to 5mC, thus allowing direct binding of Mbd3 to 
this modification in a manner structurally analogous to the binding of remaining 
Mbd members to 5mC. 
Consistent with this hypothesis, we found that Mbd3 localization patterns 
are similar to Tet1 localization patterns, and Mbd3 is enriched at genes with high 
levels of hydroxymethylation (Wu et al., 2011c).  Like Tet1, Mbd3 is associated 
largely with CpG-rich promoters bound by Polycomb, and is required for normal 
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expression of many of these targets. Mbd3 localization requires Tet1, suggesting 
that hydroxymethylation plays a role in Mbd3 recruitment in vivo. Finally, we 
found that Mbd3 preferentially binds to 5hmC-containing probes relative to 5mC-
containing probes. Thus, our data are most consistent with a model in which 
Tet1-catalyzed hydroxymethylation serves to recruit Mbd3/NURD complex, and 
thus Mbd3/NURD may be an effector that mediates some of the effects of 
hydroxymethylation on gene expression. 
Interestingly, we found that purified Mbd3/NURD also bound to unmodified 
probe in vitro, but that this binding was qualitatively distinct from binding to the 
5hmC probe: the shifted band was more discrete and of higher mobility when the 
probe was hydroxymethylated. One potential explanation for this could be the 
binding location of the complex on the probe, as probe bound at either end 
should have higher mobility than internally bound probe. At present it is unclear 
to us why Tet1KD, which results in incomplete loss of 5hmC in vivo, almost 
completely abolishes Mbd3 localization. Given the increase in 5mC observed in 
Tet1KD cells at loci that lose 5hmC (Ficz et al., 2011a; Wu et al., 2011a), and our 
observation that 5mC inhibits Mbd3 binding, we speculate that genomic regions 
with 5mC intermixed with 5hmC might be unfavorable for Mbd3 binding. Future 
studies will dissect the details of how Mbd3/NURD differentially interacts with 
unmodified and hydroxymethylated DNA, and with hemi-modified or 
symmetrically modified DNA. 
 Finally, we found that KD of either Mbd3 or Brg1 results in reduction of 
bulk levels of 5hmC in vivo. This could occur via several possible mechanisms: 
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as two examples, Mbd3 could bind to a region of hydroxymethylated DNA and 
recruit Tet enzymes to hydroxylate adjacent methylcytosines, or Mbd3 could bind 
to hydroxymethylated loci and protect them from further steps in a demethylation 
pathway. Either way, the extensive interdependency between these factors – 
Tet1 is necessary for Mbd3 localization, Mbd3 is necessary for cytosine 
hydroxymethylation – is reminiscent of other co-dependencies in chromatin 
pathways. For instance, Polycomb is required for H2A.Z incorporation at 
promoters of developmental genes in ES cells, and H2A.Z is in turn required for 
Polycomb binding (Creyghton et al., 2008). Dissecting the detailed mechanistic 
basis for such interdependencies is a challenging goal for studies on chromatin 
regulation. 
Together, these data describe the first downstream effector that regulates 
expression of 5hmC-marked genes, suggesting that 5hmC plays a role in gene 
regulation beyond serving simply as an intermediate in a demethylation pathway. 
It will be of great interest in future studies to determine whether Mbd3 also plays 
a role in 5hmC biology in other contexts such as early embryos (Inoue and 
Zhang, 2011a; Iqbal et al., 2011), imprinting (Reese et al., 2007), or neurons 
(Kriaucionis and Heintz, 2009). Finally, our discovery of an interdependent 
regulatory network consisting of 5hmC and two antagonistic chromatin regulators 
suggests that control of gene expression by opposing chromatin regulators is a 
common regulatory strategy in pluripotent ES cells.  
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Materials and Methods 
RNAi-Mediated Knockdown 
RNA interference using endoribonuclease III digested siRNAs (esiRNAs) 
was performed as described previously (Fazzio et al., 2008b), using E14 mouse 
ES cells. All KDs were performed for 48 hours to achieve effective KD, but avoid 
some indirect effects of prolonged loss of chromatin regulators. Stable Mbd3 KD 
lines were made by infection of ES cells with lentiviral shRNA vectors from the 
TRC library (Open Biosystems). 
Expression Profiling 
Array hybridizations were performed at the Sandler Asthma Basic 
Research (SABRE) Center Functional Genomics Core Facility as described 
previously (Fazzio et al., 2008a). For each single and double KD, a linear model 
was fit to the comparison to estimate the mean log2 (fold change) in 2 biological 
replicates and to calculate a moderated t-statistic, B statistic, false discovery rate 
and p-value for each probe. Adjusted p-values were produced as decribed 
previously (Holm, 1979). All procedures were carried out using functions in the R 
package limma (Gentleman et al., 2004; Smyth, 2004) or made4 (Culhane et al., 
2005) in R/Bioconductor. Enrichment of Gene Ontology terms was performed 
with DAVID 6.7 (Dennis et al., 2003). mRNA data are available at GEO, 
accession GSE31008. 
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ChIP-Seq 
Chromatin immunoprecipitation and deep sequencing library construction 
were performed using minor modifications of established protocols (Barski et al., 
2009; Lee et al., 2006b) (Supplementary Experimental Procedures). Data are 
available at GEO, accession GSE31690. 
Multivariate linear regression model 
Multivariate linear regression was used to predict factors that regulate 
Mbd3/Brg1-target genes. 38 ChIP-seq datasets were divided into 40 bp bins 
surrounding the TSS of each gene that changed oppositely upon Mbd3 KD and 
Brg1 KD, with another bin representing the gene body. Binding of each of the 38 
factors was compared to gene expression changes (see Supplementary 
Experimental Procedures for details).  
Mbd3/NURD Purification 
An ES cell line with a C-terminal 6-Histidine-3X FLAG tag placed just 
upstream of the Mbd3 stop codon was constructed as described in the 
Supplementary Experimental Procedures. Mbd3/NURD complex was purified 
from ~ 4 X 108 of these cells by sequential affinity purification steps using FLAG-
M2 Agarose followed by TALON Agarose beads.  
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EMSA Assays 
EMSA assays were performed on 5% polyacrylamide 0.5X TBE gels. 
Biotinylated probes corresponding to +529 - +628 of the Tgfb1 gene were made 
by PCR using Phusion polymerase and NTPs containing either unmodified, 
methylated, or hydroxymethylated dCTP. The PCR primer sequences for probe 
construction were: biotin-TGCCTCTTGAGTCCCTCGCATC and 
AGTGGGTGTTCTTAAATAGGGGAGCT. Binding reactions were performed in 
1X Binding Buffer (LightShift Chemiluminescent EMSA Kit; Thermo Scientific) 
with 100 mM KCl, 8% glycerol, 0.02% NP-40, 5 mM MgCl2, 0.85 μg BSA, 30 ng 
yeast genomic DNA, 1 mM ATP, and with or without 1 μl purified Mbd3/NURD or 
recombinant Mbd3, as indicated. After electrophoresis, samples were transferred 
to charged Nylon membrane and probed with streptavidin-HRP according to the 
instructions in the EMSA kit. 
Dot Blotting 
2-fold serial dilutions of genomic DNA were denatured in 0.4 M 
NaOH/10mM EDTA at 95C for 10 min, then added to an equal volume of cold 2M 
ammonium acetate (pH 7.0). Denatured DNA samples were spotted onto 
nitrocellulose. The membrane was washed with 2XSSC buffer and then UV 
cross-linked. Membrane was blocked with 5% non-fat milk for 1 hr and incubated 
with rabbit anti-5hmC, detected by HRP-conjugated secondary antibody and 
enhanced chemiluminescence. 
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Immunofluorescence 
Cells were resuspended in PBS, cytospun onto glass slides, fixed in 4% 
paraformaldehyde for 10 min at room temperature, washed twice with PBS, 
permeabilized in 2% TritonX-100-PBS for 10 min, and blocked with 5% FBS and 
0.1% TritonX-100 in PBS for 15 min at room temperature. Cells were incubated 
with primary antibody diluted 1:500 with 5% FBS and 0.1% Triton X-100 in PBS 
for 30 minutes at  room temperature, washed 3 X 5 min with PBS, and incubated 
for 30 min at room temperature with secondary antibody diluted 1:200 with 5% 
FBS and 0.1% Triton X-100 in PBS. DAPI was added in mounting medium 
(Vectashield, H1500). 
Supplemental Experimental Procedures 
Chromatin Immunoprecipitation 
80% Confluent ES cells were crosslinked by addition of formaldehyde 
(Sigma) to a final concentration of 1% and incubated at room temperature (RT) 
for 10 min. Crosslinking was quenched with 125mM Glycine. Cells were washed 
twice with ice cold PBS containing PMSF, collected in PBS, and pelleted at 
1000g for 5 min, at 4oC. Cell pellets were either flash frozen in liquid nitrogen and 
stored in -80oC, or processed immediately. Pellets were resuspended in 270 µl 
SDS-Lysis Buffer (1% SDS, 10mM EDTA and 50mM Tris-Cl, pH 8.1.) including 
protease inhibitor complex (Sigma) and PMSF (Sigma).  Samples were sonicated 
in a Bioruptor (UCD-200) at high setting 3 times for 15 min of 30sec on/30sec off 
cycles, followed by a 14000 rpm spin at 4oC for 1 hour. Supernatants were 
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transferred to a new tube and pellets were resuspended in 150 µl of lysis buffer 
and processed in a Bioruptor using the previous settings for two more 15 min 
cycles. Supernatants were collected after a 13000 rpm spin at 4oC for 10 min and 
combined with supernatants from the previous centrifugation. Chromatin was 
quantified by measuring A260. 50 µg of protein A magnetic beads (NEB) were 
washed twice with 600 µl of 0.1M sodium phosphate (NaK) buffer (pH 8.0) and 
antibody was coupled in 200 µl NaK buffer for 30min at RT. Antibody coupled 
beads were blocked with 5mg/ml BSA-PBS solution for 1hr at 4οC. 70 µg of 
chromatin for each immunoprecipitaton was diluted 1:10 in IP-Blocking buffer 
(5mg/ml BSA and 5µg/ml yeast tRNA in 0.01% SDS, 1.1% Triton X-100, 1.2mM 
EDTA, 16.7mM Tris-Cl (pH 8.1), 167mM NaCl), combined with antibody coupled 
magnetic beads and incubated at 4oC overnight (up to 16 hours). Magnetic 
beads were washed once with RIPA buffer (0.1%SDS, 10mM Tris (pH 7.6), 1mM 
EDTA, 0.1% Na-Deoxycholate, 1% Triton X-100); 3 times with NaCl buffer (0.5M 
NaCl in RIPA); 3 times with LiCl buffer (0.3 M LiCl, 0.5% NP40, 0.5% Na-
Deoxycholate in RIPA); twice with 0.2% TritonX-100 TE buffer  and once with TE 
buffer (pH 8.0). 
Washed beads were resuspended in 300 µl TE and incubated at 65oC 
overnight in after adding the following (final concentrations): SDS (3%), 
proteinaseK (1mg/ml) (Sigma) and glycogen (0.5mg/ml) (Ambion). Eluted 
material was transferred to a new tube and the beads were resuspended in 150 
µl 0.5M NaCl-TE solution and incubated at 65oC for one hour. Eluted materials 
were combined and PCI (Phenol-Chloroform-Isoamylalcohol) extracted using 
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phase-lock tubes (Eppendorf). Ethanol precipitated ChIP DNA was treated with 
RNAse (Qiagen) for 2 hours and with CIP for an hour at 37oC (NEB calf alkaline 
phosphatase - 0.25U/µl in 1x NEB Buffer 3). Reactions were then cleaned up 
with Qiagen MiniElute spin columns. 
Antibodies 
The following antibodies were used in this study for ChIP, IP, Western 
blotting, dot blotting and meDIP: Mbd3, Abcam (ab3755) and Bethyl (A302-
528A); Brg1, Bethyl (A300-813A); Pol II, Santa Cruz (sc-899X); Ac-H4, Millipore 
(06-866); H3, Abcam (ab1791); Tet1, Millipore (09-872); 5hmC, Active Motif 
(39791); 5mC, Eurogentec (BI-MECY-0500); Mta1, Bethyl (A300-280A); and 
beta-actin, Sigma (A1978). 
Generation of stable Mbd3 knockdown lines 
80 - 90 % confluent 293T cells were transfected with 15μg of shRNA 
containing vector, 20μg of pCMVΔ8.9 and 3μg of pVSV-G using 
Lipofectamine2000 in OPTI-MEM. The viral supernatant was collected at 48h 
and 72h and filtered with low protein binding 0.2μM syringe filters. To enrich the 
virus yield, virus producing cells were lysed with 2 cycles of freeze-thaws using 
liquid nitrogen and a 37oC water bath. After pelleting the cellular debris with 
centrifugation, the supernatant was filtered and combined with the filtered growth 
medium. Virus was concentrated with ultracentrifugation at 4 οC, 27 000 rpm for 2 
hr in an SW28 rotor. The viral pellet was resuspended in 15 ml HBS and ultra 
filtered with Ultracell-100k filters (Amicon). ES cells were infected in 2ml ES 
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medium containing 6mg/ml Polybrene® in a 6well-plate with 100ul of the 
concentrated virus. The next day, cells were re-plated on 10cm dishes and 
antibiotic selection started 24hr after the infection. Resistant colonies were 
picked, expanded and tested for knockdown efficiency via RTqPCR and Western 
blotting.  
Isolation of hydroxymethylated DNA 
Hydroxymethylated DNA was isolated as previously described (Song et 
al., 2011). Briefly, purified genomic DNA, sonicated into short fragments (200-
500 bp), was incubated with β-glucosyltransferase (β-GT) and UDP-6-N3-
Glucose, which resulted in N3-glucosylated-5hmC. Modified DNA was then 
biotinylated using copper-free click chemistry. Biotinylated DNA was isolated 
using streptavidin magnetic beads and eluted in 100mM DTT for 2hrs at room 
temperature. Isolated DNA was cleaned up using Micro Bio-Spin 6 spin columns 
(Bio-Rad) followed by MinElute reaction clean up columns (Qiagen) and 
subjected to qPCR. 
Deep sequencing library construction 
ChIP material was pre-size selected (100 to 800bp in size) on a 2% TAE 
agarose gel using the MiniElute columns QiaQuick (Qiagen). Gel purified DNA 
fragments were blunt ended and phosphorylated with the EPICENTRE End-it-
Repair kit (1X buffer, 0.25mM dNTPs,1mM ATP, 1ul/50ul reaction of Enzyme 
mix) for 1hr at RT and cleaned up with Qiagen MiniElute spin columns. 
Adenosine nucleotide overhangs were added using EPICENTRE exo- Klenow for 
 84
45min at RT (with 0.2mM dATP). Illumina genome sequencing adaptors were 
then ligated using the EPICENTRE Fast-Link ligation kit: 11.5µl A tailed DNA 
eluted from a MinElute column was mixed with 1.5µl 10X ligation buffer, 0.75µl 
10mMATP, 0.5µl Illumina DNA adaptors and 1µl ligase. The reaction was 
incubated for 1hr at RT and subsequently supplemented with 7.5 µl water, 1µl 
10X buffer, 0.5µl 10mM ATP and 1µl ligase, and incubated overnight at 16οC. 
The ligation reaction was cleaned up with MiniElute columns (with an 
additional wash step to eliminate all the excess adaptors) and the adaptor ligated 
fragments were amplified by PCR as follows: 
0.75 µl of each Illumina genomic DNA sequencing primers, 6µl 10xPfx buffer 
1.8µl 10mM dNTPs, 1.2µl 50mM MgSO4 and 1µl Pfx DNA polymerase 
(Invitrogen) were added to 30µl DNA template in a 100ul reaction.  The cycling 
parameters were: 1. 94οC 2’; 2. 94οC 15’’; 3. 65οC 1’; 4. 68οC 30’’; 5. repeat 
from step 2 16 times; 6. 68οC 5’. The PCR product was size selected (250 to 450 
bp) from a 2% TAE agarose gel using QiaQuick columns (Qiagen). Gel purified 
fragments were finally precipitated with Sodium acetate and ethanol and pellets 
were resuspended (25nM final concentration) in TE buffer and subjected to 
SOLEXA single-read sequencing at the UMass Medical School deep sequencing 
core facility. 
Mbd3 datasets were collected for two independent ChIP samples using 
independent antibodies (obtained from Bethyl and Abcam). Datasets were well-
correlated (Figure S7), although the Bethyl library exhibited higher genome-wide 
background than the Abcam library and so was not used for most analyses. 
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Nonetheless, all major biological conclusions were reproduced with either 
dataset. 
Multivariate Adaptive Regression Splines (MARS) Model 
MARS models were used to predict the log2 expression fold change upon 
Mbd3 knockdown using 38 ChIP-seq datasets (log2 of histone modification and 
transcription factor binding; called features). Each gene is divided into 41 bins, 40 
100-bp bins for its promoter region ([-2k, +2k] around TSS) and one bin for the 
remaining gene body (from +2k to the transcriptional termination site), and the 
bin that leads to the highest correlation coefficient is chosen as representative 
signal for that gene. Feature selection was performed and the final model 
includes 12 features. A MARS model is judged by Person's correlation coefficient 
(R) between the predicted and experimental log2 expression change at 10-fold 
cross-validation. The MARS modeling was performed using the earth() function 
in R, and the relative importance of a histone mark or binding of a transcription 
factor in the final model is calculated using two criteria: percentage of models 
that use the feature during feature selection, and generalized cross validation 
(GCV) (Friedman, 1991). We constructed the model with the 568 transcripts on 
which knocking down Brg1 and Mbd3 had opposite effects (Brg1 upregulated 
and Mbd3 downregulated, or Brg1 downregulated and Mbd3 upregulated) that 
were significant in both knockdown datasets (adjusted p-value < 0.01). 
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Gene Targeting 
A targeting construct containing one homology arm extending from ~2.5 
kb upstream of the Mbd3 transcriptional termination site (TTS) to just 
downstream of the TTS and a second homology arm extending from just 
downstream of the TTS to ~3.2 kb further downstream was constructed. 
Sequence encoding 36 amino acids 
(SGRGSHHHHHHAGMDYKDHDGDYKDHDIDYKDDDDK) that include a 6-
Histidine and a triple FLAG tag was inserted just upstream of the normal Mbd3 
stop codon. A LoxP-Hygromycin-LoxP selection cassette was introduced at the 
upstream end of the second homology arm and a diptheria toxin A (DTA) 
counterselection cassette just downstream of the second homology arm (Figure 
S2-6A). 25 g of the resulting plasmid was linearized with Asc I and 
electroporated into E14 ES cells. Clones were screened by PCR, followed by 
western blotting to ensure correct integration (Figure S6B). 
Mbd3/NURD Purification 
Approximately 4X108 Mbd3-6His-3XFLAG ES cells were collected after 
trypsinization from eight 15 cm dishes, washed once in PBS and lysed by 
sonication in Lysis buffer (50mM Tris, pH 7.4, 250mM NaCl, 0.1% Tx-100), plus 
1X HALT protease inhibitors (Thermo). The lysate was clarified twice by 
centrifugation and incubated for three hours in 200 l of FLAG M2 Agarose bead 
slurry (Sigma) that had previously been equilibrated in Lysis buffer. Beads were 
washed five times and Mbd3/NURD complex was eluted five times with 0.5 
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mg/ml 3XFLAG peptide (Sigma) in Lysis Buffer, with 15 minute incubations prior 
to recovery of each elution. Pooled FLAG elutions were incubated with 100 l of 
pre-equilibrated TALON Agarose beads for two hours, washed five times with 
Lysis buffer, and eluted five times in Lysis buffer + 250 mM imidazole (10 minute 
incubations per elution). Pooled eluates from the TALON beads were dialyzed 
overnight in Buffer H (25 mM Hepes-KOH pH 7.6, 0.1 mM EDTA, 0.5 mM EGTA, 
2 mM MgCl2, 20 % glycerol, 0.02 % NP40) with 100 mM KCl, aliquoted, flash-
frozen in liquid nitrogen and stored at -80 oC. 
Purification of recombinant Mbd3 or Mbd1-MBD 
The longest isoform of Mbd3 (Mbd3a) and the first 75 amino acids 
(comprising the methylcytosine binding domain) of Mbd1 were PCR amplified 
from mouse ES cell cDNA with Phusion DNA polymerase, cloned into pCR2.1, 
sequence verified, sub-cloned into pQE80L in frame with an N-terminal six 
histidine tag encoded within the vector and transformed into BL21 pLysS cells. 
200 ml cultures were grown to early log phase, induced with 0.5 mM IPTG for 3.5 
hours, washed with PBS and frozen. Frozen pellets were re-suspended in lysis 
buffer (see Mbd3/NURD purification above), sonicated several times and 
centrifuged twice to clarify lysates. Lysates were incubated with 200 l of TALON 
resin for 2 hours, washed 6 times with 1 ml lysis buffer and eluted 5 times in lysis 
buffer containing 250 mM imidazole. Purified proteins were dialyzed overnight in 
Buffer H (see above), aliquoted and flash frozen in liquid nitrogen. 
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Figure 2-1 
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Figure2-1. Antagonistic effects of Brg1 and Mbd3 on gene expression in 
mES cells. 
(A) Gene expression data for single and double knockdowns of Brg1, Mbd3, 
Ash2l, Suz12, p400, and Tip60. Heatmap shows pairwise Pearson correlation 
coefficients for the 21 datasets. Four major clusters emerge, roughly 
corresponding to Brg1, Mbd3, Ash2l/Suz12, and Tip60/p400. 
(B) Principal Component Analysis. Genes significantly misregulated (adjusted p-
value < 0.01) in any data set from (A) were subjected to principal component 
analysis. Shown are individual data sets plotted along three most prominent 
principal components, which account for 87% of the total variance in gene 
expression. 
(C) Mbd3 and Brg1 antagonistically regulate a common set of genes. 
Unsupervised clustering of genes misregulated in both the Mbd3 KD and Brg1 
KD datasets (adjusted p-value < 0.05). Clustering was performed on data sets 
containing either Mbd3 KD or Brg1 KD (or both), as well as the Tip60, p400, 
Suz12 and Ash2l single KD datasets for contrast. 
(D) Genes regulated by both Mbd3 and Brg1 tend to be moderately to highly 
expressed. Shown are mRNA abundance distributions (expressed as log2 of 
microarray probe intensity) for all genes, and for genes regulated by either or 
both Mbd3 and Brg1. 
See also Figure S2-1, Table S2-1 and Table S2-2. 
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Figure 2-2 
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Figure2-2. Genome-wide localization of Mbd3. 
(A) Mbd3 KD effects on gene expression. Genes are sorted by change in mRNA 
abundance in Mbd3 KD, shown here in Log2. 
(B) Mbd3 was mapped across the genome in ES cells by ChIP-Seq. Left panel: 
Mbd3 mapping data for 4 kb surrounding the transcriptional start sites (TSS) of 
17,992 genes for which Mbd3KD gene expression data were available, with 
heatmap yellow saturating at 20 ppm normalized abundance. Right panel: 
published data for Brg1 (Ho et al., 2009a). In both panels, genes are sorted as in 
(A). 
(C) Mbd3 binds downstream of Brg1. Averaged data for all genes in (B) are 
shown relative to the TSS. 
(D) Mbd3 and Brg1 physically associate with antagonistically-regulated genes. 
Mbd3 and Brg1 data are shown for all genes as in C, or only for genes 
significantly repressed by Mbd3 and activated by Brg1. 
(E) Mbd3 and Brg1 physically associate. Western blots for Brg1 following 
immunoprecipitation with the indicated antibodies. 
(F) Brg1 is required for Mbd3 localization. Mbd3 was mapped genome-wide in 
Brg1 KD cells, and data for all genes are averaged and plotted as in (C). 
See also Figure S2-2, Figure S2-3, and Figure S2-4. 
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Figure 2-3 
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Figure2-3. Mbd3 directly regulates Polycomb target genes. 
(A) Mbd3 binding at Polycomb target genes. For 34 mapped factors with 
thresholded binding defined in (Kim et al., 2010a), Mbd3 binding levels (mean 
ChIP signal for 1 kb centered on the +200 position) were calculated for bound 
and unbound subsets of genes. Genes annotated as unbound by all 34 factors 
were removed from this analysis. Factors are sorted according to the relative 
Mbd3 binding at factor targets relative to nontargets. 
(B) Mbd3 binding at three ES cell “modules.” Average Mbd3 binding for all 
genes, and for the three modules defined in (Kim et al., 2010a), is plotted relative 
to the TSS. 
(C) Mbd3 binding at Polycomb targets and non-targets. For various Polycomb-
related marks, averaged Mbd3 profile is shown for bound and unbound genes. 
(D) Mbd3 binds preferentially to high-CpG promoters. Mbd3 binding data are 
averaged for high, intermediate, and low CpG (HCP, ICP, and LCP) promoters, 
as defined in (Weber et al., 2007). 
(E) Mbd3 KD affects Polycomb targets. Clustered mRNA data for KD of Suz12, 
Ash2l, Mbd3, or Brg1, and assorted double knockdowns. Genes significantly 
misregulated in any of the included datasets are shown.  
(F) Scatterplot of Mbd3 KD gene expression vs. Ash2l KD and Suz12 KD. Only 
genes showing significant misregulation in Mbd3 KD are shown. 
See also Figure S2-3 and Figure S2-5. 
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Figure 2-4 
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Figure2-4. Mbd3 and Brg1 regulate chromatin structure and transcription 
initiation at target genes. 
(A) H3 occupancy at Mbd3/Brg1 targets. H3 occupancy is plotted for control KD, 
Mbd3 KD, and Brg1 KD. 
(B) H4 acetylation at Mbd3/Brg1 targets. As in (A), for H4 acetylation. Data are 
normalized to nucleosome occupancy (H3 ChIP). 
(C) Genome-wide RNA Polymerase II (Pol II) mapping. Average TSS-aligned 
profiles of Pol II occupancy is shown for all genes for control, Brg1 KD, and Mbd3 
KD cells. 
(D) Pol II levels at the 5’ end correlate with mRNA abundance changes in Brg1 
and Mbd3 KDs. As in (C), but only for genes repressed by Mbd3 and activated by 
Brg1. 
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Figure 2-5 
 97
Figure2-5. Mbd3 associates with hydroxymethylated regions of the 
genome. 
(A) Mbd3-bound genes are associated with high levels of hydroxymethylation. 
Average hydroxymethylation data from (Wu et al., 2011a) are averaged for genes 
with the indicated levels of Mbd3 binding. 
(B) Mbd3 colocalizes with Tet1. Left panel: Tet1 (Wu et al., 2011c)  mapping data 
are shown for all named genes, sorted by Tet1 binding levels. Middle and right 
panels: Mbd3 localization is shown for control and Tet1 KD ES cells. 
(C) Mbd3 binding data for control and Tet1 KD are plotted as in Figures 2-2C,D. 
(D) qPCR validation of Mbd3 binding at 6 selected target loci in GFP or Tet1 KD. 
Shown are mean +/- sem. 
(E) Knockdowns of Tet1, Brg1, and Mbd3 do not affect protein levels of the other 
remaining factors. Knockdowns of the various factors were assayed by Western 
blot, as indicated. 
See also Figure S2-5. 
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Figure 2-6 
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Figure 2-6. Mbd3 directly binds to hydroxymethylated DNA in vitro. 
(A) Silver stain showing tandem affinity purification from untagged or Mbd3-6His-
3XFLAG ES cells. 
(B) Western Blot of purifications described in (A) for indicated proteins. Mta1 is a 
component of the Mbd3/NURD complex. Preliminary mass spec results also 
identified most other known NURD subunits in this purification (not shown).  
(C) EMSA assay using Mbd3/NURD complex and DNA probes containing 
unmodified cytosine (C), methylated cytosine (5mC) or hydroxymethylated 
cytosine (5hmC). 
(D-E) EMSA assay using recombinant mouse Mbd3 (D) or recombinant Mbd1 
methyl-binding domain (E), and various modified probes as in (C). 
See also Figure S2-6. 
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Figure 2-7 
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Figure2-7. Mbd3 is required for global hydroxymethylation in vivo. 
(A) Dot blots of 5hmC. Top panel shows positive (5hmC) and negative (5mC) 
controls for antibody specificity. Bottom panels show dilution series of genomic 
DNA isolated from the indicated knockdown ES cells. Mbd3 and Brg1 KDs have 
similar effects to Tet1KD on bulk 5hmC levels. 
(B) Thin layer chromatography of radioactively end-labeled bases from MspI-
digested genomic DNA (Ficz et al., 2011a) from the indicated knockdowns. 
(C) Quantitation of 5hmC levels (normalized to levels of T) measured as in (B) for 
5 independent replicate experiments. Columns show mean +/- sem. 
(D) Tet1 and Mbd3 knockdowns have similar effects on hydroxymethylation of 
target gene promoters. Hydroxymethylated DNA was isolated by capture of 
biotin-glucosylated 5hmC-containing DNA fragments (Song et al., 2011), and fold 
enrichment over input was assessed by qPCR at the indicated loci and 
expressed as fold change relative to 5hmC levels in control (EGFP) KD cells. 
Data represent mean +/- sem. 
(E) Immunofluorescence imaging of Mbd3 and 5hmC. Immunofluorescence 
images are pseudocolored blue (DAPI), green (Mbd3), and red (5hmC) for the 
indicated KDs – top panel shows 5hmC data only, bottom panel shows all 3 
colors. 
See also Figure S2-7. 
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Supplemental Figure 2-1 
 
 103
Supplemental Figure 2-1. Complete gene expression dataset. 
(A) Data from all 21 KD datasets (each representing the average of 2 replicates). 
A clustered heatmap of gene expression changes is shown. The most variant 
300 genes that were significantly differentially expressed in each single KD were 
used for clustering. 
(B) The Log2 (fold change) values of each gene significantly misregulated 
(adjusted p-value < 0.05) in both Mbd3 KD and Brg1 KD datasets were averaged 
across all 21 KD datasets (referred to below as “row averages”). Genes were 
separated into the indicated bins based on the direction of their expression 
changes in Brg1 KD and Mbd3 KD, and the mean and standard deviation of the 
row averages of the genes in each bin were calculated and plotted above. 
Notably, genes upregulated in both KDs were increased on average in all 21 
KDs, and similar results hold for those downregulated in both KDs. Conversely, 
genes downregulated in Brg1 KD and upregulated in the Mbd3 KD show no 
general trend. P-values testing whether each bin is non-zero are indicated. 
(C) Transcript levels of several target genes (downregulated in Brg1 KD and 
upregulated in Mbd3 KD) were assayed by RTqPCR in murine ES cells knocked 
down for the indicated regulators. Levels are shown relative to EGFP control KD. 
Levels are given as the average +/- sem of 3 technical replicates. Each 
experiment was performed at least two times with similar results. 
(D) As in (C), for Mbd3 and Brg1 knockdowns using a completely independent 
set of siRNAs. While KDs were slightly less efficient with this set of esiRNAs, the 
general effects of Brg1 and Mbd3 KD on target gene expression are maintained. 
(E) As in (C), for knockdowns of additional NuRD (left) and BAF (right) subunits. 
Knockdown of NURD components Mta1, Hdac1, or double KD of Hdac1 and 
Hdac2 recapitulated Mbd3’s effects at five target genes. Similarly, knockdown of 
BAF subunit Smarcc1 recapitulated the effects of Brg1 knockdown on target 
genes, whereas knockdown of Polybromo, a subunit of the distinct PBAF 
complex, did not affect the genes assayed. 
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Supplemental Figure 2-2 
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Supplemental Figure 2-2. Mbd3 localization is robust to antibody source. 
TSS-aligned Mbd3 mapping datasets are shown for the main dataset in this 
manuscript (obtained using an antibody from Abcam), and for a second dataset 
(using an antibody from Bethyl Laboratories). Data are sorted by Tet1 binding as 
in Figure 2-5. Data from the Bethyl antibody had more sequencing reads but 
higher genome-wide background, and so almost all figures are derived from the 
Abcam dataset, with the exceptions of Figures S2-3A and 5B, which use both 
datasets combined for the increased read number. 
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Supplemental Figure 2-3 
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Supplemental Figure 2-3. Genome-wide maps of Mbd3 binding in ES cells. 
(A) Example genomic loci showing binding data for Mbd3 (this study), Brg1 (Ho 
et al., 2009a), and Tet1 (Wu et al., 2011c). The first four panels show regions 
surrounding individual genes of interest. The third panel down shows a long 
(chr6:50,300,000-54,010,000) region surrounding the HoxA gene cluster (boxed 
in red), which is then magnified as indicated. The HoxB cluster is shown to the 
right of the HoxA cluster, as indicated. Notably, Mbd3 is strongly associated with 
all 4 Hox loci (as shown here, and data not shown), with similar localization 
pattern to Tet1 (Wu et al., 2011c) and polycomb group proteins (Boyer et al., 
2006). 
(B) Sheared input samples and DNA immunoprecipitated with the indicated 
antibodies (or IgG from non-immunized rabbits) were subjected to quantitative 
PCR using promoter-proximal primers specific for the indicated genes. Shown is 
the enrichment, relative to input, obtained in each of the ChIP samples. Data 
shown are averages +/- sem of three technical replicates. Experiment was 
repeated twice with similar results. 
(C) Mbd3-repressed genes are associated with Mbd3. Genes are grouped by the 
effects of Mbd3 KD as indicated, and averaged Mbd3 binding levels are plotted 
relative to gene’s TSS. Among genes that could be mapped to TSSs with Mbd3 
binding data, 250 genes were downregulated at this level in the Mbd3 KD (log2 
change > 0.75), 17301 were unchanged, and 441 were upregulated. 
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Supplemental Figure 2-4. Brg1 and Mbd3 bind to common targets near the 
TSS. 
(A) Mbd3 is weakly associated with enhancers. Loci associated with the 
enhancer-specific histone mark H3K4me1 (Zentner et al., 2011) were used as 
anchors for mapping Mbd3, Brg1, and Tet1 mapping data. Averaged data for all 
enhancers are plotted.  
(B) As in (A), but here a heatmap view shows all 75,772 putative enhancers, 
sorted by the extent of Brg1 binding to the enhancer. Brg1 and Tet1 both show 
strong localization to enhancers (and their localization is somewhat correlated), 
whereas Mbd3 levels are rarely above background at enhancers. 
(C) Mbd3 and Brg1 colocalize at promoters in vivo. Mbd3 mapping data are 
sorted by the extent of Mbd3 binding to the 1 kb surrounding the TSS, and shown 
in the left heatmap. Brg1 binding to the 1 kb surrounding the TSS is shown on 
the right, with median binding shown in red and the bottom and top quartiles 
shown in grey/blue. 
(D) Distribution of Mbd3 binding near promoters of genes regulated by both 
Mbd3 and Brg1. Shown are boxplots quantifying Mbd3 enrichment by ChIP-seq 
for genes misregulated in Mbd3 KD and Brg1 KD data sets. Genes were 
separated into the indicated categories based on the direction of the gene 
expression changes upon Mbd3 KD and Brg1 KD. Mbd3 enrichment was 
calculated by quantifying normalized read count within 1 kb in each direction from 
the transcription start site. Note that only one category, genes upregulated upon 
Mbd3 KD and downregulated upon Brg1 KD, was significantly enriched for Mbd3 
binding compared to average. 
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Supplemental Figure 2-5 
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Supplemental Figure 2-5. Multivariate prediction of Mbd3 function. 
(A) Scatterplot showing good fit between a multivariate linear regression model 
predicting Mbd3 KD gene expression changes (x axis), and measured data (y 
axis). Line shows x=y. Here, model is used to predict genes exhibiting 
antagonistic regulation by Mbd3 and Brg1. Importantly, a highly similar model 
also significantly captures measured data for all 19,602 annotated genes 
(R=0.13; p-value < 2.2e-16), but because of the noise introduced by ~18,000 
genes that are unaffected by Mbd3 KD (either unbound by Mbd3 or unaffected by 
Mbd3 binding due to redundant regulators) we focused on the model presented. 
(B) Major contributors to the model. Top twelve localization datasets (features) 
contributing to the multivariate model (R=0.4 at 10 fold cross validation; p-value < 
0.0018) are shown as a bar graph, with each bar showing the fraction of MARS 
models that pick the feature during feature selection, and the white number on 
the bar showing the total decrease in GCV (generalized cross validation) upon 
removing the feature from all models that include the feature.  
(C) Mbd3-repressed genes are associated with high levels of hydroxymethylated 
cytosine, but low levels of methylated cytosine. 5hmC and 5mC mapping data 
(Ficz et al., 2011a) are aligned by TSS, and averaged for the indicated sets of 
genes as defined by their mRNA abundance changes in Mbd3 KD. 
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Supplemental Figure 2-6. Mbd3/NURD binding to DNA is inhibited by 
cytosine methylation. 
(A) Strategy for generation of epitope-tagged Mbd3 ES cells. Shown are the 3’ 
end of the Mbd3 gene plus downstream sequence (below) and the targeting 
construct for introducing the C-terminal tandem 6His-3XFLAG tag (above). See 
Supplemental Experimental Procedures for details of targeting. 
(B) Expression of Mbd3 isoforms in untagged cells (E14) or cells tagged at one 
of the two copies of Mbd3, as in (A). Note that the epitope tag induces a 
molecular weight shift in all three Mbd3 isoforms expressed in ES cells, but all 
three isoforms are expressed at their normal levels. Actin is shown as a loading 
control. 
(C) Hydroxymethylated probe is not shifted by nonspecific contaminants. Extracts 
from untagged ES cells were subject to an identical purification scheme as those 
from tagged cells, and isolated material was subjected to EMSA assays. Shown 
is a side-by-side comparison of Mock purified and Mbd3 purified complexes 
bound to each of the probes from Figure 2-6. 
(D) (Above) Titration of recombinant Mbd3 in gelshift experiments using 
unmodified, methylated, and hydroxymethylated probes. Arrows (compare like 
colored arrows for each probe) indicate multiple Mbd3-shifted bands, likely 
corresponding to binding of multiple Mbd3 proteins to the relatively long DNA 
probe used for the gelshift. (Below) Image J was used to quantify the total 
amount of shifted probe (plotted on y axis) at each titration for each different 
probe. 
(E) Structural rationale for Mbd3 binding to 5hmC. Crystal structure (PDB 
accession 1IG4) of human Mbd1 complexed with methylcytosine-containing DNA 
(Ohki et al., 2001) is shown. Tyrosine 34 on Mbd1 is shown as spheres, while 
one of the two 5-methyl cytosines is shown as sticks, as indicated. Intriguingly, 
human/mouse Mbd3 differ from the Mbd1 methyl binding domain at very few 
residues, including a substitution of phenylalanine at position 34 in place of 
Mbd1’s tyrosine. The loss of the hydroxyl group caused by this substitution may 
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be required to enable binding to DNA carrying an additional hydroxyl group on 
methylcytosine. 
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Supplemental Figure 2-7. Mbd3 affects bulk 5hmC levels. 
(A) Characterization of stable Mbd3 KD cells. ES cells stably expressing two 
different shRNAs directed against Mbd3 were generated as described in the 
Supplemental Experimental Procedures. Western blot shows Mbd3 protein levels 
in standard ES cells and in two different stable KDs. Asterisk shows background 
band on Western. 
(B) Dotblot for 5hmC for the three cell lines from (A). 300 ng of DNA from each 
cell line are probed here. Note that the relatively high levels of 5hmC in line P1-5 
likely results both from incomplete knockdown of Mbd3 (A), and from increased 
DNA loading (below). 
(C) Loading control for (B). Identical amount of genomic DNA as loaded in (B) is 
shown here on an ethidium bromide-stained agarose gel. 
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Histone turnover is conserved from yeast to mice and different 
histone variants have different turnover profiles in mouse 
embryonic stem cells 
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ABSTRACT 
 Nucleosome de-stabilization is important for all DNA templated processes. 
Nucleosomal positioning and stability particularly affect the transcriptional 
regulation of underlying DNA. Recent studies suggest that histone turnover not 
only plays a role in accessibility of the regulatory DNA elements but also provides 
dynamic alternating chromatin states by replacing old nucleosomes with newly 
synthesized variants. Here we investigate the histone turnover phenomenon in 
mouse embryonic stem cells and show that it is conserved from yeast to 
mammals. We show different histone variant dynamics at specific loci. Moreover, 
we generate animals expressing inducible constructs of different histone variants, 
which will enable us to extend histone turnover studies to whole animals and 
allow us to study histone dynamics at different developmental stages and in 
different tissues in vivo. 
INTRODUCTION: 
Eukaryotic genomes are organized into chromatin through packaging with 
highly conserved basic proteins called histone proteins. The histone octamer, 
consisting of  4 pairs of 4 different histone proteins – H2A, H2B, H3 and H4 – is 
wrapped by approximately 147 bp of DNA duplex (Luger et al., 1997b) and 
creates the fundamental unit of chromatin called the nucleosome. Packed 
nucleosome arrays can be folded into higher order chromatin structures in the 
nucleus in association with the linker histone H1 (Marino-Ramirez et al., 2005). 
Both the protein composition of the histone octamer (with canonical or variant 
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histones) and post translational modifications of these histones as well as 
nucleosome positioning dictate the overall organization of chromatin that 
influences all DNA templated processes including transcription, replication and 
DNA repair. 
One of the most exciting aspects of chromatin is its potential to carry non 
DNA-based heritable information, known as epigenetic information (Henikoff et 
al., 2004; Rando and Ahmad, 2007). Evidence that chromatin carries epigenetic 
information comes from many fields, but most notably it comes from the 
observation that many epigenetic inheritance paradigms genetically require 
chromatin regulators. Cell state inheritance in metazoans requires Polycomb and 
Trithorax group chromatin regulators, whereas epigenetic inheritance in budding 
yeast requires the Sir complex, a chromatin regulating complex. Moreover, 
Polycomb has been shown to remain associated with replicating DNA in vitro, 
demonstrating that chromatin regulators can be inherited through replication in 
the absence of additional cellular machinery (Francis et al., 2009). 
Mammalian development is characterized by a progressive loss of 
pluripotency, as stem and progenitor cells differentiate into specific cell types. 
Establishment and maintenance of cellular identity requires mechanisms that 
control specific sets of genes. These mechanisms utilize gene activation and/or 
silencing when and where they are needed (Orlando, 2003). These differential 
gene expression patterns are different in different types of cells with identical 
DNA sequence, underscoring the non-genetic mechanisms responsible for 
genomic plasticity (Theise and Wilmut, 2003). These considerations make 
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embryonic stem cells a key subject for epigenetic research, as these pluripotent 
cells can generate a wide range of distinct epigenetic states that can then self-
propagate in the absence of inducing signals (Loebel et al., 2003; Nishikawa et 
al., 2007).   
 Over the past decade many studies have aimed to identify the factors that 
allow this plasticity. In order to answer this question many of those focused on 
ES cell specific transcriptional networks (Boyer et al., 2005; Wang et al., 2006). 
Although tissue specific transcription factors are very important in defining 
cellular identity, chromatin related factors also play important roles in maintaining 
and stabilizing it. While a defined set of transcription factors are sufficient to 
reprogram differentiated cells into embryonic stem cell state (Takahashi and 
Yamanaka, 2006; Wernig et al., 2007) or to another differentiated cell state (Zhou 
et al., 2008), reprogrammed cells nonetheless show preference to re-differentiate 
into their cell type of origin (Hu et al., 2010), and they may carry residual DNA 
methylation signatures of their originating cells (Kim et al., 2010b; Kim et al., 
2011). Moreover, perturbation of chromatin regulators such as DOT1L, Suv39h1 
(Onder et al., 2012), and Brg1 (Singhal et al., 2010) affects the efficiency and 
kinetics of cell reprogramming, indicating a role for chromatin factors in 
maintenance and disruption of epigenetic states. Not only are chromatin 
regulators involved in reprogramming of differentiated cells to the pluripotent 
state, but a multitude of chromatin factors are also involved in the process of 
differentiation. Genetic ablation of factors ranging from Polycomb to the TIP60 
complex to components of the NURD complex and others have all been shown 
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to have defects in either the maintenance of the pluripotent state, or defects in 
differentiation (Boyer et al., 2006; Creyghton et al., 2008; Fazzio et al., 2008b; 
Kaji et al., 2006). 
Thus, genetic dissection of the pluripotent state increasingly implicates 
chromatin regulators as major factors in controlling pluripotency, and this has 
motivated a large number of analyses of the chromatin state of ES cells. Relative 
to that of most differentiated cell types, embryonic stem cell chromatin possesses 
several unusual properties. Histone methylation patterns typical of both PcG and 
TrxG – repressive and active marks respectively – co-exist at promoters of 
developmentally important transcription factors (“master regulators”) in 
embryonic stem cells. Moreover, these so called ‘bivalent domains’ carrying both 
active and repressive histone modifications largely resolve upon differentiation 
(Bernstein et al., 2006). Thus, this ambivalent state of chromatin may have a role 
in ES cell plasticity by providing a flexible arrangement in the organization of the 
pluripotent genome. Another unusual characteristic of chromatin structure in 
embryonic stem cells has been revealed by FRAP (Fluorescence Recovery after 
Photobleaching) experiments. Although the inner core of nucleosomes, i.e the 
histone H3 and H4 tetramer, is very stable in differentiated cells (Kimura and 
Cook, 2001), FRAP studies showed that histones have a “hyper dynamic” nature 
in ES cell chromatin; they present high fluorescence recovery rate suggesting a 
high histone turnover (Meshorer et al., 2006). Compellingly, the fluorescence 
recovery rates substantially decrease upon differentiation to neural precursor 
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cells suggesting a role for histone dynamics in the maintenance of genomic 
plasticity.  
Metazoan genomes encode multiple isoforms of the histone proteins, not 
only encoding the canonical histone proteins but also a set of replication 
independent variants (Jenuwein and Allis, 2001; Turner, 2000). Histone variants 
are localized to distinct chromatin domains, and they play roles in wide variety of 
processes (Talbert and Henikoff, 2010), suggesting that histone variants may 
also play important roles in other chromatin-based processes such as control of 
the pluripotent state in embryonic stem cells. 
Two versions of canonical histone H3 are encoded in mammals, and are 
deposited during genomic replication – H3.1 and H3.2. In addition, mammals 
carry three replication-independent H3 variants. These include the centromere 
specific H3 CenpA, the sperm specific H3t (Witt et al., 1996), and H3.3, which is 
expressed throughout the cell cycle and maintained during differentiation (Ahmad 
and Henikoff, 2002; Wu and Gilbert, 1981).  In humans, mice and flies H3.3 is 
expressed from 2 different genes, H3.3A and H3.3B. Both genes encode the 
same protein sequence, but have  distinct promoter elements (Frank et al., 2003) 
and untranslated regions (Bramlage et al., 1997), suggesting differential 
transcriptional and post-transcriptional regulation. H3.3 protein was found to be 
associated with transcriptionally active genes and regulatory elements (Ahmad 
and Henikoff, 2002; Goldberg et al., 2010), as well as transcriptional elongation 
(Wirbelauer et al., 2005). In line with these findings, H3.3 was found to be 
enriched for active chromatin marks (Hake et al., 2006; McKittrick et al., 2004; 
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Sutcliffe et al., 2009). Its distinct distribution in the genome (Drane et al., 2010; 
Goldberg et al., 2010; Mito et al., 2005) and importance especially for certain cell 
types (Orsi et al., 2009; Sakai et al., 2009; Torres-Padilla et al., 2007) suggest 
that H3.3 is more than just a surrogate for H3.1 and it is functionally important for 
normal chromatin regulation.  
While the microscopy studies described above for embryonic stem cells by 
necessity measure whole-genome histone dynamics, histone dynamics have 
been studied at nucleosomal resolution in other cell types and other organisms 
(Deal et al., 2010; Dion et al., 2007; Goldberg et al., 2010; Mito et al., 2005, 
2007; Rufiange et al., 2007) . Both in yeast and fly, histone turnover is non-
uniform across the genome, and rapid turnover coincides with specific DNA 
elements, such as chromatin boundaries or Polycomb/Trithorax response 
elements (Deal et al., 2010; Dion et al., 2007; Mito et al., 2007). Findings in those 
studies, notably rapid histone turnover at promoter regions of actively transcribed 
genes, suggest that histone turnover may have an important role in gene 
regulation, as higher histone turnover rates may provide higher probability of 
DNA element exposure. Also intriguing is a connection between histone 
replacement and epigenetic inheritance – epigenetically-regulated loci such as 
homeotic genes in flies or subtelomeric genes in yeast are associated with 
stably-bound nucleosomes, whereas the boundaries to epigenetic domains are 
associated with rapid turnover. Despite the proposed models, not much is known 
about the mechanism of action or the biological consequences of hyper dynamic 
chromatin states.  
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 We therefore set out to measure histone dynamics in embryonic stem 
cells across the mouse genome. Previous studies in yeast utilized genetic “pulse 
chase” systems for induction of epitope-tagged histones to follow incorporation of 
newly-generated histones into chromatin over time course experiments. We 
chose to adapt this strategy to embryonic stem cells, and generated cell lines 
carrying inducible epitope-tagged histone variants in order to measure dynamic 
incorporation of H3.3 and of MacroH2A2 genome-wide in ES cells. Our results 
extend prior studies of H3.3 mapping in ES cells to a dynamic regime, and reveal 
completely novel facets of the biology of the H2A variant macroH2A. Finally, we 
have generated mice from the various ES cell lines, enabling future studies on 
tissue-specific histone dynamics in a multi-cellular organism. 
RESULTS AND DISCUSSION 
In order to assay histone variant dynamics genome-wide in embryonic 
stem cells and cell types derived from them, we generated ES cells based on the 
murine ES line KH2 (Beard et al., 2006) carrying a genomically-integrated 
cassette to enable tetracycline-inducible expression of HA-tagged histone 
variants (Figure 3-1A) confirmed by southern blots (Figure 3-1B). Cell lines 
were generated for several different histone variants, including canonical H2A, 
macroH2A2 and H3.3 as well as stable cell line for inducible knockdown of 
macroH2A1.2.  But here we detail results from two – MacroH2A2 (hereafter 
called Macro), and H3.3. Figure 3-2A shows Western blots for HA-H3.3 and HA-
Macro expression over a time course of doxycycline induction. In both cell lines, 
epitope-tagged histone expression was detectable by 2-3 hours, and increased 
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over ~12 hours. Even after 12 hours of induction, ectopically expressed tagged 
histone levels were orders of magnitude lower than the endogenous proteins 
levels; barely detectable at 12hrs with respect to endogenous H3 (Figure 3-2B 
red arrow). However, this did not perturb the key biology of ES cells, as even 
after 72 hours of overexpression, ES colonies did not differentiate as assessed 
by cell morphology, continued to express pluripotency markers such as Oct4, 
Sox2 and Nanog (Figure 1C), and stained positively for alkaline phosphatase 
(Figure 3-1D) (See also Supp Figure3-1 for colony staining for Oct4). 
Genome-wide dynamics of H3.3 replacement in mES cells 
 Because metazoans encode distinct histone H3 variants for replication-
coupled deposition (H3.1) and replication-independent replacement (H3.3) 
(Ahmad and Henikoff, 2002), we sought to determine whether the pulse-chase 
approach that is necessary in budding yeast (Dion et al., 2007; Rufiange et al., 
2007) provided any additional insights into histone dynamics. In other words, if 
steady-state mapping of H3.3 localization is sufficient to identify sites of histone 
replacement genome-wide, what additional information is gained by explicitly 
including a pulse chase component to such mapping experiments? 
 We therefore focus first on the dynamics of H3.3 replacement, the well-
studied H3 variant involved in replication-independent nucleosome replacement. 
ES cells carrying tetracycline-inducible HA-H3.3 were treated with doxycycline for 
0, 3, or 6 hours, and HA-H3.3-containing chromatin was mapped genome-wide 
by chromatin immunoprecipitation followed by Illumina deep sequencing (ChIP-
Seq). Sequencing reads were mapped back to the genome. Importantly, HA 
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mapping at t=0 (no doxycycline) did not show enrichment over specific loci but 
rather genome-wide nonspecific background, demonstrating the specificity of the 
anti-HA antibody. 
Because H3.3 replacement is strongly associated with the 5’ ends of 
genes (Mito et al., 2005, 2007), we aligned all annotated genes by their 
transcription start sites (TSSs), and averaged all mapped reads at each position 
relative to the TSS (Figure 3-3A). Consistent with studies in flies and mouse 
embryonic stem cells (Goldberg et al., 2010; Mito et al., 2005, 2007), we find that 
H3.3 is localized to two peaks surrounding the TSS. Also consistent with 
published reports, we found that H3.3 levels correlate with transcription rate of 
the associated gene (Figure 3-3B). Our results with H3.3 localization at the 6 
hour time point are therefore broadly consistent with known aspects of H3.3 
localization. 
Importantly, we also observe additional details of H3.3 localization not 
observed in steady-state mapping studies. Specifically, at the 6 hour time point, 
as in Goldberg et al, H3.3 peaks surrounding the TSS of highly-transcribed 
genes are of similar heights, suggesting that nucleosome turnover upstream and 
downstream of the TSS occurs at similar rates. However, at earlier time points 
the upstream peak is lower. We interpret these results as demonstrating that 
H3.3 replacement is more rapid downstream of the TSS than upstream, a result 
that is consistent with the more rapid downstream nucleosome replacement 
measured by a metabolic labeling method (Deal et al., 2010) and consistent with 
the greater number of short transcripts generated downstream of promoters 
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relative to upstream (Core and Lis, 2008). Moreover, H3.3 dynamics observed at 
polycomb bound regulatory elements in flies are also present in mouse 
embryonic stem cell genome at regions occupied by polycomb proteins Rnf2 and 
Suz12 (Figure 3-3C). 
These results imply that under steady-state mapping conditions (e.g. 
Goldberg et al), and after extended induction in a pulse chase system, 
nucleosomes exhibiting moderate to high turnover rates become saturated with 
H3.3. Thus, even for the canonical turnover variant, we find that kinetic studies 
provide additional information on histone dynamics.  
Specific histone chaperones are responsible for the differential localization 
of H3 variants. The canonical H3s, H3.1 and H3.2, associate with CAF-1 that 
travels behind the replication fork with the proliferating cell nuclear antigen 
(PCNA) and assembles into chromatin in a replication coupled manner 
(Shibahara and Stillman, 1999). While in yeast the only H3 variant associates 
both with Caf1 and HirA, in vertebrate HIRA binds only to replication independent 
H3 variant H3.3 (Tagami et al., 2004). The amino acid substitutions in the histone 
fold domain in H3.3 allow this selective association with replication independent 
chromatin assembly factors (Ahmad and Henikoff, 2002). Recent studies showed 
that HIRA is not the only chaperone for H3.3 assembly. In fact, various 
chaperones are responsible for the differential targeting of H3.3 throughout 
mammalian chromatin. While HIRA is responsible for H3.3 deposition at 
promoter regions and transcribed regions of active genes; Daxx-Atrx complex is 
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required for H3.3 localization at pericentric heterochromatin and telomeres 
(Drane et al., 2010; Lewis et al., 2010; Wong et al., 2010).  
Additional comparison of our data set with static mapping in the presence 
and absence of different H3.3 chaperones suggested that most of the dynamics 
are result of neither HIRA nor Daxx/Atrx function (Figure 3-3D). Moreover, 
enrichment of high turnover rates at active promoters and enhancers indicate the 
existence of a separate H3.3 chaperone responsible for the H3.3 dynamics at 
regulatory regions. Interestingly, DEK is another novel H3 chaperone which has 
been shown to have H3.3 specificity in vitro and is potentially responsible for 
H3.3 deposition at regulatory elements (Sawatsubashi et al., 2010);  
Genome-wide dynamics of MacroH2A replacement 
We next extended our studies to a histone variant with unknown dynamic 
properties, macroH2A. MacroH2A (also known as H2AFY) is unique among 
histone variants in that it has a large, distinct C-terminal domain, which includes 
a small stretch of basic amino acids and a putative leucine zipper motif. While the 
N-terminal domain of the protein shares 65% amino acid sequence similarity with 
the canonical H2A, the C-terminal domain (also known as the macro domain) is 
almost twice as big as the canonical H2A and has no relation to other histones 
(Chadwick and Willard, 2001a). The macroH2A genes are located on different 
chromosomes: macroH2A1 on 13 and macroH2A2 (also known as H2AFY2) on 
chromosome 10. The two genes have nevertheless the same architectural 
genomic organization with conserved exon-intron boundaries except for the 
splicing variant site in macroH2A1. MacroH2A1 encodes two splicing variants 
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macroH2A1.1 or macroH2A1.2; both are conserved in mammals. MacroH2A2 is 
80% identical to macroH2A1.2 and it is 98% conserved between mice and 
human (Chadwick and Willard, 2001a; Costanzi and Pehrson, 2001; Zhang et al., 
2005). Although they are preferentially expressed at different levels in different 
cell types in a tissue, two proteins seem to share overall similar genomic 
localization; for instance, they both localize to the inactivated X chromosome (Xi). 
The enrichment of macroH2A on the Xi chromosome of female mammalian cells 
was interpreted as evidence for its role in silencing (Costanzi and Pehrson, 
1998), even though the association of macroH2a with the Xi appears to occur 
after the random inactivation of the second X chromosome (Chadwick and 
Willard, 2001a). Moreover, macroH2a localization to Xi depends on the non 
coding RNA XIST but is not required for the inactive state. When XIST is 
conditionally deleted, gene silencing is maintained despite the loss of macroH2a 
on Xi (Csankovszki et al., 1999). It is evident that macroH2a function extends 
beyond its role in MCB formation in Xi since it localizes to other chromatin 
domains and autosomal chromosomes. In addition, some of the organisms that 
do not undergo X inactivation still express this H2A variant (Abbott et al., 2005). 
Since MacroH2A has not been extensively studied and has not been 
characterized dynamically, we therefore also examined MacroH2A dynamics 
using our pulse-chase system. We mapped MacroH2A genome-wide at 3, 6, and 
12 hours after induction of the HA-tagged variant by ChIP-Seq as for H3.3. 
Reads were mapped back to the genome and genes were aligned by TSS as 
above.  
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Because MacroH2A localization has not been characterized in embryonic 
stem cells, we chose unbiased K means clustering for our initial analysis of 
MacroH2A localization patterns. We found K=4 yielded the most informative 
distinctions between clusters (Figure 3-4A). One cluster was associated with 
background levels throughout the time course and will not be discussed further. 
Two clusters were comprised of genes exhibiting increasing levels of MacroH2A 
throughout the time course (see also Figure 3B), with MacroH2A being found in 
domains several kb long either upstream (Cluster 2) or downstream (Cluster 3) of 
the TSS. Finally, we found a surprising cluster of genes with very high levels of 
MacroH2A surrounding TSSs early in the time course (Figure 3-4A). The tagged 
MacroH2A appears to become gradually depleted at later time points which we 
believe due to the normalization method used for deep sequencing data sets 
(See below). 
These results are consistent with two populations of MacroH2A-containing 
chromatin that can be distinguished by their dynamic behavior. We infer that the 
TSS-proximal MacroH2A that is enriched at early time points before being lost 
represents a rapidly-exchanging population of MacroH2A that is present at low 
steady-state occupancy, while the larger blocks that are gradually gained 
correspond to higher-occupancy MacroH2A domains undergoing either slow 
turnover or replication-coupled assembly. Because deep sequencing datasets 
are normalized to account for sequencing depth, enrichment of the rapidly-
exchanging population is high at early time points before assembly of HA-
MacroH2A into the slower subpopulations, whereas at later time points 
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normalization relative to the widespread MacroH2A in cold domains results in a 
diminishing TSS-proximal peak. 
MacroH2A2 generally localizes TSS-proximally in ES cells and MEFs 
Our results showing rapid TSS-proximal turnover of macroH2A were quite 
surprising, given published results showing that MacroH2A1 localizes in broader 
domains covering silent genes. This raised the concern that we might artifactually 
be driving inappropriate MacroH2A into promoters as a result of overexpression 
of this variant. We therefore carried out genome-wide localization of endogenous 
MacroH2A.2, in wild type cells not bearing the tagged variant, using ChIP-Seq 
with an antibody against the MacroH2A2 protein. As shown in Figure 3-4, 
MacroH2A was strongly localized to a peak surrounding the TSS in embryonic 
stem cells and in embryonic fibroblasts. Thus, our findings of TSS-proximal 
macroH2A turnover do not reflect artifactual incorporation during overexpression. 
We next sought to compare Macro localization to turnover. To our 
surprise, only a fraction of promoters with steady-state MacroH2A peaks were 
subject to rapid MacroH2A replacement, with roughly half of the TSS-proximal 
peaks showing no incorporation of HA-MacroH2A even after 12 hours of 
induction (Figure 3-5A). We sought characteristics of the genes with promoter 
peaks of MacroH2A with and without high rates of turnover, finding that those 
promoters exhibiting rapid MacroH2A turnover were generally expressed at much 
higher levels than those genes with MacroH2A peaks that were not dynamic 
(Figure 3-5B). Taken together, our data show that MacroH2A.2 is widely 
localized to a large number of promoters in both pluripotent cells and in 
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differentiated cells, but that it is dynamic at only a subset of its binding sites. We 
are currently repeating these experiments for publication, and we are 
investigating the functional consequences of the difference in MacroH2A.2 
dynamics by assaying gene expression defects in knockout ES cells lacking 
MacroH2A.2. 
Generation of turnover mice 
To date, the majority of studies on histone dynamics have been carried 
out in cell culture systems. However, it will be of great interest in the future to 
understand tissue-specific differences in chromatin dynamics, both under control 
conditions and in response to environmental perturbations. Because embryonic 
stem cells are the cell type used for generating knockout and transgenic mice, 
we decided to generate mice carrying the tetracycline-inducible epitope-tagged 
histone variants. 
HA-H3.3 ES cells were injected into Black6 X DBA F2 generation 
blastocysts, and embryos were implanted into pseudopregnant females. We 
obtained multiple chimeric animals with high levels of contribution from the ES 
strain background, and found after mating that several of these animals had 
germline contribution from the tet-inducible ES cells (Figure 3-6A). 
As a proof of principle to survey tissue-dependent expression of the 
epitope-tagged H3.3, transgenic tet-HA-H3.3 mice were fed doxycycline (in 
drinking water) for several days. Figure 3-6B shows Western blots against HA 
for mice with or without doxycycline feeding. HA-H3.3 induction is observed in 
nuclear protein extracts from liver samples of animals that are fed with 
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doxycycline for 4 or 8 days but not in un-induced animals. These animals will 
therefore provide a unique and exciting resource for characterization of histone 
dynamics in different tissues from an animal. 
METHODS 
Targeting & Stable Cell Line Derivation 
The unique EcoRI restriction site of the pBS31 vector used in order to 
integrate the Kozak sequence followed by HA tag and BspH1 sequences. cDNA 
of various histone variants ((H2a-MMM1013-98478233; H2Az-MMM1013-
9498090; MacroH2a2- MMM1013-9201250; H3.3-MMM1013-98478016, H1o- 
MMM1013-65296, Open Biosystems & human H3.1-Kind gift of Eric Campeau)) 
was cloned into pBS31 vector using the unique BspH1 restriction site. This 
allowed the ectopic expression of histone variants with HA tag. Construct 
integrity was confirmed by western blot showing the inducible expression of HA- 
tagged histone variants. pBS31 expression/targeting vector contains a PGK 
promoter followed by an ATG start codon, an Frt site, and  a splice acceptor-
double poly A cassette. Tetracycline response element is at the upstream of 
CMV minimal promoter. The minimal promoter is followed by an SV40 poly-A 
signal at the downstream of the unique EcoRI cloning site. When pBS31 vector is 
electroporated into KH2 embryonic stem cells along with a Flpe recombinase 
expressing vector pCAGGS, it is integrated into the Collagen1a1 locus at the Frt 
site. In the mean time, Frt-flanked PGK-neomycin resistance cassette is targeted 
to the upstream of the promoterless, ATG-less hygromycin resistance cassette 
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located at downstream of the Frt site in the Col1A locus. KH2 embryonic stem 
cells also harbor the reverse trans-activator of tetracycline response element 
(M2-rtTA) at the ROSA26 locus and express it under the control of the ROSA26 
promoter (Beard et al., 2006) . Together, the components of this system enable 
tetracycline induction of the epitope-tagged histone variant of choice in 
embryonic stem cells from a genomically-integrated construct. Hygromycin 
selection was started a day after the electroporation of HA-tagged variant 
constructs. Twenty days of selection of hygromycin resistance yielded numerous 
colonies, which were verified for proper flip-in to the Coll1a1 locus by southern 
blotting.  
Generation of Tet-inducible MacroH2A1.2 KD Mice: 
Potent shRNAs were designed to knockdown macroH2A1.2 using RNAxs 
web server (http://rna.tbi.univie.ac.at/cgi-bin/RNAxs). Five different shRNAs, 
designed by the web server, were embedded in microRNA structure to allow Pol 
II derived expression of shRNAs as described by Zhou H. et al. (Zhou et al., 
2005). Designed structure was flanked by EcoRI restriction sites and the 
resulting DNA sequence was synthesized by Epoch Biolabs. shRNAmir 
sequence was PCR amplified and cloned into the pBS31 targeting vector via the 
unique EcoRI site. Inducible for the macroH2a1.2 knockdown, stable embryonic 
stem cells were generated by successful genomic integration, which was 
confirmed by southern blot. Knockdown efficiency of different clones was tested 
by KD induction followed by both RT-qPCR and western blot (See 
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Supplementary Figure 3-1B). These embryonic stem cells were injected into 
Black6 X DBA F2 generation blastocysts to obtain inducible macroH2A KD mice.   
Southern Blot and Confirmation of Induction: 
Genomic DNA was isolated from selected colonies and SpeI-digested. 
Digestion of Col1a1PL plasmid with PstI/XbaI yielded the 850bp band which was 
gel purified and used as a 3’ internal probe for the southern blotting. The wild 
type allele yielded a 6.2 kb band whereas the successfully flipped-in HA tagged 
histone variant inducible allele had a 4.1 kb band and a 6.7 kb band for the Frt-
containing knock-in allele. Activation of the TetOn HA-tagged histone expression 
was carried out by addition of 2-5ug/mL doxycycline hyclate (Sigma D9891) to 
the culture media. Cells were collected at different induction time points and 
induction of HA tagged histone variants in ES cells observed via western blot. 
Tris-Tricine PAGE and Western Blot 
16% TrisTricine poly acrylamide gel was prepared with 30% (w/v) 
Acrylamide/Bis (4mL) and 3.3mL Tris.Cl-SDS solution (3M Tris base and 3% 
SDS pH 8.45), 1.3gr glycerol, fresh 10% (w/v) ammonium per sulfate (APS) and 
TEMED. Samples were resuspended in 2X Tricine sample buffer (100mM 
Tris.Cl, 200mm DTT, 0.02% Commassie Blue G250 and 0.1% SDS, pH 6.8) and 
run with anode (40mM Tris.Cl pH 8.9) and cathode (100mM TrisCl, 100mM 
Tricine, 0.1% SDS) buffers. PVDF membrane transfer was conducted in Tris-
Glycine transfer buffer. The membrane was blocked with 10% milk and incubated 
with antibody (Beta Actin (ab8224), HA (ab9110), Pan H3 (ab1791)). 
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Immunofluorescence Staining of KH2 cells 
Cells were washed with PBS and fixed with 4% paraformaldehyde in 200 
ul PBS for 10 minutes at room temperature. After washed for twice, 5 minutes 
with PBS, they were permeabilized and blocked with 5% FBS and 0.1% Triton X-
100 in PBS at room temperature for 15 minutes. Cells were then incubated with 
primary antibody diluted 1:100 with 1% FBS and 0.1% Triton X-100 in PBS for 30 
minutes at room temperature. Next they were washed 3 times with PBS for 5 
minutes and incubated with secondary antibody diluted 1:200 with 1% FBS and 
0.1% Triton X-100 in PBS for 30 minutes at room temperature. During the first 
PBS wash DAPI was added and incubated for 5 minutes. Cells then washed 3 
more times for 5 minutes with PBS (Starting from the secondary antibody 
addition all steps were performed in dark). 
Cytospin & Immunofluorescence Staining of KH2 cells 
ES cells were trypsinized and pre-plated in gelatin coated dishes and 
incubated at CO2 incubator for an hour in order to eliminate the feeder MEFs. 
Cells were washed with PBS and counted. 5X105 to 1X106 cells were 
resuspended in 200ul 4% formaldehyde in PBS, fixed for 30 minutes at room 
temperature. Fixed cells were then washed twice with PBS for 5 minutes at room 
temperature. After attachment of the cells on glass slides via cyto-spin, they were 
permeabilized and blocked with 5 %FBS and 0.1% TritonX-100 in PBS for 15 
minutes at room temperature. Exact same protocol described above was applied 
to the slides. 
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Alkaline Phosphatase Staining 
Formaldehyde-fixed ES colonies were incubated for 15 minutes at 37 °C 
with alkaline phosphatase (SK5100, Vector labs) which was diluted in 100mM 
Tris-HCl pH 8.5, pluripotent ES colonies stained red. 
MEF Isolation from MacroH2A-HA Chimeras 
Mouse embryos were isolated at embryonic day E12.5 followed by the 
removal of internal organs. Carcasses were minced in the presence of 0.25% 
Trypsin-EDTA and incubated at 37ºC for 20 minutes. MEF medium was added 
and cell suspension was titrated followed by plating cells onto 15 cm culture 
dishes, one to two dishes per embryo. Cells were cultured at 37°C, 3% CO2, and 
5% O2 for 48 hours. The cells were then trypsinized and frozen. 
Geneotyping for Inducible Mice 
Rosa26 locus was amplified with cycling parameters of 95o C for 45" (1 cycle); 95 
o C for 45", 55 o C for 45", 72 o C for 1' (35cycles); 72 o C for 5' (1 cycle); 4 o C) 
with primer set of three (1: 5'AAAGTCGCTCTGAGTTGTTAT; 2: 
5'GCGAAGAGTTTGTCCTCAACC; 3: 5'GGAGCGGGAGAAATGGATATG) for 
discrimination of wild type versus M2 reverse trans-activator (M2rtTA) integration. 
Wild type allele product size is 500 base pairs (bp), M2rtTA allele product size is 
300bp. Col1A locus was amplified with touchdown PCR protocol with cyclin 
parameters of  95°C for 1' (1 cycle); 94°C for 30", 70°C for 45" (2cycles); 94°C for 
30"; 68°C for 45" (5cycles); 94°C for 20", 66°C for 1' (29cycles); 4°C, with a 
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primer set of 3 (col/frt-B:CCCTCCATGTGTGACCAAGG; 
col/frtA1:GCACAGCATTGCGGACATGC; 
col/frtC1:GCAGAAGCGCGGCCGTCTGG) for the discrimination of wild type 
versus frt integration of tagged variants. While wild type allele product size is 331 
bp, flip-in allele product size is 551 bp. 
Time Course & ChIP-Seq 
80% Confluent ES cells were pre-plated on gelatin and incubated for 45 
min for the removal of the feeder MEFs. Then they were split in three plates each 
of which was induced in different time points by the addition of final 2ug/mL 
doxycycline hyclate. At the end of the doxycycline incubation, the cells were 
crosslinked with formaldehyde (Sigma) to a final concentration of 1% and 
incubated at room temperature for 10 min. Crosslinking was quenched with 
125mM Glycine.  
Cells were washed twice with ice cold PBS containing PMSF then 
collected in PBS and pelleted at 1000g for 5 min, at 4οC. Cell pellets were either 
flash frozen in liquid nitrogen and stored in -80οC, or continued with sonication. 
Pellets were resuspended in 270 µl SDS-Lysis Buffer (1% SDS, 10mM EDTA 
and 50mM Tris-Cl, pH 8.1.) including protease inhibitor complex (Sigma) and 
PMSF (Sigma).  Samples were sonicated in Bioruptor (UCD-200) at high settings 
for 3 times 15 min- 30sec on/30sec off cycle- followed by 14000 rpm spin at 4οC 
for 1 hour. Supernatants were transferred to a new tube and pellets were 
resuspended in 150 µl of lysis buffer and processed in Bioruptor at previous 
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settings for two more 15 min cycles. Supernatants were collected after 13000 
rpm spin at 4οC for 10 min and combined with supernatants from the previous 
centrifugation. Chromatin amount was quantified with Abs 260 reading. 50 µg 
magnetic proteinA beads (NEB) were washed twice with 600 µl 0.1M sodium 
phosphate (NaK) buffer (pH 8.0) and antibody-coupled in 200 µl NaK buffer for 
30min at room temperature. Antibody-coupled beads were blocked with 5mg/ml 
BSA-PBS solution for 1 hour at 4οC. 70 µg of chromatin for each 
immunoprecipitaton was diluted to 1:10 in IP-blocking buffer (5mg/ml BSA and 
5µg/ml yeast tRNA in 0.01% SDS, 1.1% Triton X-100, 1.2mM EDTA, 16.7mM 
Tris-Cl (pH 8.1), 167mM NaCl) combined with antibody coupled magnetic beads 
and incubated at 4οC overnight (up to 16 hours). Magnetic beads were washed 
once with RIPA buffer (0.1%SDS, 10mM Tris (pH 7.6), 1mM EDTA, 0.1% Na-
Deoxycholate, 1% Triton X-100); 3 times with NaCl buffer (0.5M NaCl in RIPA); 3 
times with LiCl buffer (0.3 M LiCl, 0.5% NP40, 0.5% Na-Deoxycholate in RIPA); 
twice with 0.2% TritonX-100 TE buffer  and once with TE buffer (pH 8.0). 
Washed beads were resuspended in 300 µl TE and incubated at 65 οC 
overnight with final concentration of 3% SDS, 1mg/ml proteinaseK (Sigma) and 
0.5mg/ml glycogen (Ambion). Eluted material was transferred to a new tube and 
the beads were resuspended in 150 µl 0.5M NaCl-TE solution and incubated at 
65οC for an hour. Eluted materials were combined and PCI (Phenol-Chloroform-
Isoamylalcohol) extracted using phase-lock tubes (Eppendorf). Ethanol 
precipitated ChIP DNA was treated with RNAse (Qiagen) for 2 hours and with 
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CIP for an hour at 37οC (calf alkaline phosphatase NEB; in 1x NEB Buffer3, 
0.25U/µl CIP, reaction clean up with Qiagen MiniElute spin columns)  
Deep Sequencing Library Construction.  
ChIP material was then gel-purified (100 to 800bp in size) from a 2% TAE 
agarose gel using the MiniElute columns QiaQuick (Qiagen). Gel-purified DNA 
fragments were blunt-ended and phosphorylated with the EPICENTRE End-it-
Repair kit (1X buffer, 0.25mM dNTPs,1mM ATP, 1ul/50ul reaction of enzyme 
mix) for 1 hour at room temperature and cleaned up with Qiagen MiniElute spin 
columns. Adenosine nucleotide overhangs were added using EPICENTRE exo- 
Klenow for 45min at room temperature (with 0.2mM dATP). Illumina genome 
sequencing adaptors were then ligated using the EPICENTRE Fast-Link ligation 
kit: 11.5 µl A-tailed DNA eluted from a MinElute column was mixed with 1.5µl 
10X ligation buffer, 0.75µl 10mMATP, 0.5 µl Illumina DNA adaptors and 1 µl 
ligase. The reaction was incubated for 1 hour at room temperature and 
subsequently supplemented with 7.5 µl water, 1µl 10X buffer, 0.5µl 10mM ATP 
and 1µl ligase, and incubated overnight at 16οC.The ligation reaction was 
cleaned up with MinElute columns (with an additional wash step to eliminate all 
the excess adaptors) and the adaptor-ligated fragments were amplified by PCR 
as follows: 0.75 µl of each Illumina genomic DNA sequencing primers, 6µl 10xPfx 
buffer 1.8µl 10mM dNTPs, 1.2µl 50mM MgSO4 and 1µl Pfx DNA polymerase 
(Invitrogen) were added to 30µl DNA template in a 100ul reaction.  The cycling 
parameters were: 1. 94οC for 2’; 2. 94οC for 15’’; 3. 65οC for 1’; 4. 68οC for 30’’; 5. 
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repeat from step 2 16 times; 6. 68οC 5’. The PCR product (250 to 450bp in size) 
was gel purified from a 2% TAE agarose gel using the QiaQuick columns 
(Qiagen). Gel-purified fragments were finally precipitated with 300 mM sodium 
acetate and absolute ethanol. Pellets were then resuspended (25nM final 
concentration) in TE buffer and sent for SOLEXA sequencing at the UMass 
Worcester core deep sequencing facility. 
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Figure 3-1 
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Figure 3-1. Targeting strategy and conformation of genomic integration 
A)  The unique EcoRI restriction site downstream of tetracycline response 
element and CMV minimal promoter, used to integrate HA tagged histone 
variants into the pBS31 expression/targeting vector. HA-tagged variant 
integration site is followed by an SV40 poly A signal. The Frt site upstream of 
tetracycline response element allows the targeting of the construct downstream 
of Col1A locus in the presence of Flpe recombinase. In the mean time the PGK 
promoter followed by an ATG start codon gets integrated upstream of 
promoterless, ATG-less hygromycin resistance gene through the same Frt site. 
Genomic integration of the targeting construct is enabled by electroporation of 
KH2 embryonic stem cells with pBS31 vector along with a Flpe recombinase 
expressing vector pCAGGS. Correct integration of the construct renders KH2 
cell resistant to hygromycin and allows for selection of stable cell lines. 
Expression of reverse trans-activator of tetracycline response element (M2-rtTA) 
under control of the ROSA26 promoter required for doxycycline responsiveness.  
B)  Southern blot performed on genomic DNA isolated from hygromycin 
resistant colonies. Correct integration of flipped in allele yield in two distinct 
bands, 6.7kb and 4.1kb (pointed out with red arrow). 
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Figure 3-2 
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Figure 3-2. Ectopic expression of tagged histone variants does not affect 
pluripotency. 
A) Time course induction of genomically integrated tagged histone variants. 
Upper blot shows HA tagged H3.3 and lower blot shows HA tagged MacroH2A 
expression blotted with HA antibody. No Dox and 2 hours of induction do not 
show HA tagged expression and only detectable after 3 hours of induction. 
B) 16% Tris-Tricine gel was used to separate HA tagged H3.3 (red arrow) 
from endogenous H3 proteins and blotted with pan H3 antibody (blot at the far 
right bottom); showing that ectopically expressed tagged H3.3 level is far less 
than endogenous proteins. 
C) RT-qPCR performed on total RNA extracted from cells induced or un 
induced (20 hrs) for expression of tagged histone variants and we did not 
observe change in the levels of core pluripotency factors. 
D) ES colonies are stained for alkaline phosphatase and didn’t show 
difference in alkaline phosphatase levels after 72hrs induction compared to un-
induced counterparts. 
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Figure 3-3 
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Figure 3-3. H3.3 turnover is similar to H3.3 turnover observed in flies. 
A) HA tagged H3.3 cells are induced for several hours and chromatin immune 
precipitated with HA antibody and deep sequenced. Heat map on the right 
shows HA tagged H3.3 enrichment at 6 hours post induction while the one on 
the left shows enrichment in 3 hours post induction. Genes are ordered by their 
expression levels and aligned by the transcription start sites (TSS is signified by 
the green line). 
B) H3.3 enrichment is most prominent in highly expressed genes (red line) at 
downstream of TSS after 3hrs of induction (Graph on the left). After 6 hours of 
induction (graph on the right), nucleosomes both upstream and downstream of 
TSS are saturated with H3.3 in highly and moderately (red and maroon lines 
respectively) expressed genes. 
C) H3.3 turnover also correlates with polycomb protein bound genes 
exemplified by Suz12 and Rnf2 occupied genes. 
D) H3.3 dynamics at 6 hours post induction in H3.3 occupied loci of Atrx null 
cells signifies Atrx independent dynamics (fair green line). H3.3 dynamics at 6 
hours of induction in H3.3 occupied loci of HIRA null cells signifies HIRA 
independent dynamics (lower bright green line). 
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Figure 3-4 
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Figure 3-4. MacroH2A shows different turnover patterns and dynamics at 
differentially expressed genes. 
A) Unbiased K means clustering of 3, 6 and 12hr induced tagged MacroH2A 
ChIP-Seq experiments that are aligned by TSSs yielded in 4 different clusters 
with distinct turnover rates and localization with respect to transcription start 
sites. First cluster (in green frame) shows genes that show no enrichment of 
tagged variant incorporation even in later time points, suggesting no or very low 
MacroH2A turnover. Cluster2 (in red frame) shows very rapid histone turnover 
evident by the high enrichment at early time point (at 3hr) and the appearance of 
gradual reduction in MacroH2A enrichment is due to normalization artifact 
because of this high turnover rate at early time points stays steady while slower 
turnover regions gets enriched MacroH2A in later time points. Clusters 3 and 4 
(purple and blue frames respectively) show slow turnover rate, with gradual 
enrichment of MacroH2A at later time points (6hr and 12hrs) at downstream and 
upstream of TSS respectively. Meta gene analysis (at the right hand side of the 
heat map) summarizes turnover rates of each cluster at different time points with 
respect to TSS. 
B) Expression levels (x-axis) plotted against the percentage of genes (y-axis) 
in each cluster (Cluster1, 2, 3 and 4; as green, red, purple and blue 
respectively). High turnover rate, observed in cluster 2 corresponds highly 
expressed genes’ transcription start site. 
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Figure 3-5 
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Figure 3-5. Genome wide MacroH2A2 localization in mES cells and MEFs 
A) Genome wide averaged localization of endogenous MacroH2A around the 
TSSs, in mouse ES cells and MEFs (their differentiated counter parts). 
B) In both mES and MEFs endogenous MacroH2A shows similar overall 
localization profiles when aligned by the TSS. High enrichment of endogenous 
MAcroH2A around the TSS further support the integrity of high turnover profile 
observed in time course experiments (Figure3-4A) and the observation is not 
driven by overexpression. Endogenous MacroH2A is enriched at genes with 
different GO terms in ES and MEF cells, chromatin regulators, nucleotide 
metabolism, developmental genes in ES versus; odorant receptors and sensory 
perception in MEF cells.  
C) Shows scatter plot of MacroH2A enrichment in MEF versus ES cells. 
D) ChIP-qPCR validation of endogenous MacroH2A occupancy in wild type 
ES cells compared with macroH2A2 null ES cells, as negative control. 
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Figure 3-6 
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Figure 3-6. Generation of turnover mice. 
A) HA-H3.3 ES cells were injected into Black6 X DBA F2 generation 
blastocysts (which have black coat color), and embryos were implanted into 
pseudopregnant females. We obtained multiple chimeric animals with high 
levels of contribution from the HA-H3.3 ES strain (which have agouti coat color) 
background, evident by enrichment of agouti coat color in F1 generation. 
(Injection picture is from the Transgenic/Gene Targeting Facility of Oregon 
Health & Science University, www.ohsu.edu/research/transgenics/images.shtml) 
B) F2 generation genotyping showed that several of these animals had 
germline contribution from the tet-inducible ES cells. Wild type allele of Rosa26 
locus where the M2rtTA resides has PCR product of ~500 base pairs (bp) while 
the M2rtTA containing allele has product size of ~300 bp. Wild type allele of 
Col1A locus has PCR product size of 331 bp, while the tet-inducible cassette 
integrated allele has product size of 551 bp. 
C) Animals heterozygous for both Rosa26 and Col1A locus induced with 
feeding with doxycycline containing water (2mg/L doxycycline with 10g/L 
sucrose) for several days and animals sacrificed at different time points. Various 
tissues harvested, washed with PBS and flash frozen in liquid nitrogen. 
Expression of HA-H3.3 is observed in 4 days and 8 days induced animals but 
not in No Dox control animal, nuclear extracts from liver tissues. TBP-α is used 
as nuclear protein loading control. 
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Supplemental Figure 3-1 
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Supplemental Figure 3-1. Confirmation of targeting construct integrity via 
transient transfection and other confirmed stable cell lines 
A) Several constructs including HA tagged H2Az and H3.1 confirmed via 
transient transfection of rtTA expressing, Tet-ON PC12 cells. Those constructs 
were tried for targeting as well yet did not yield in genomically integrated stable 
ES cells (data not shown). 
B) MEFs isolated from chimeras express HA tagged MacroH2A. 
C) On the other hand we managed to generate stable inducible knockdown of 
macroH2A1.2; later which we had injected into blastocysts and obtained 
transgenic animals. 
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Supplemental Figure 3-2 
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Supplemental Figure 3-2. Ectopic expression of histone variants does not 
affect Oct4 levels and tagged variants can integrate into ES cell chromatin. 
A) ES cell colonies, bearing inducible HA tagged H3.3, are immune 
fluorescent (IF) stained either with HA (red channel) or with Oct4 (green 
channel) antibody; samples counter stained with DAPI (blue channel). Both 
uninduced (-Dox) and 24hrs induced (+Dox) colonies showed similar Oct4 
levels.  
B) Similar results observed as in Supp Figure3-2A for HA tagged MacroH2A 
bearing ES cell colonies. 
C) In order to have higher resolution images of the ES cells expressing tagged 
variants single cell suspensions were prepared and cytospinned on to positively 
charged glass slides. Cells IF stained with HA (red channel) and DAPI (blue 
channel). H3.3 enrichment show more peripheral enrichment in the nucleus  
D) MacroH2A more significantly enriched in DAPI dense loci consistent with 
its heterochromatin association. 
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CHAPTER 4 
 
 
Final Conclusions and General Discussion 
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The work presented in this dissertation characterizes the dynamic 
regulation of embryonic stem cell chromatin. We approached our studies by 
focusing on chromatin remodeling, DNA modifications and histone variants, their 
genome-wide localization and turnover. Our studies, described in chapter 2, 
revealed novel relationships between coactivator and corepressor complexes 
working antagonistically in the regulation of a common group of target genes in 
ES cells. Moreover, they revealed the interdependencies between chromatin 
remodeling, DNA methylation, DNA hydroxymethylation and the 
hydroxymethylating enzyme Tet1. On the other hand, our ES cell histone 
turnover system (chapter 3), provided deeper insight into both the histone 
turnover phenomenon and histone dynamics of different histone variants in 
pluripotent chromatin and in comparison with its differentiated counterparts.  
Mbd3/NURD and BAF complexes antagonistically regulate common targets  
Our results demonstrated that two integral components of two remodeling 
complexes; one mostly associated with repression and the other with activation, 
Mbd3 and Brg1, respectively, co-occupy several hundred genes.  RNAi mediated 
depletion of these factors revealed that this co-occupancy is functional. While 
Mbd3 depletion resulted in increased expression; Brg1 depletion caused 
decreased expression of common target genes. Interestingly a double KD of 
these factors resulted in wild type-like expression profile, suggesting a role for 
this antagonistic relationship in fine tuning the expression levels of these genes. 
Our findings dovetail the theme of “bivalent” chromatin domains, in which 
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activation- and repression- associated posttranslational histone modifications that 
are produced by two antagonistic chromatin modifying complexes, H3K4me3 and 
H3K27me3, respectively, co-occupy developmentally important regulatory genes 
(Bernstein et al., 2006). Unlike H3K4me3 levels which appear to be dispensable 
for expression of most genes in ES cells (Jiang et al., 2011), Mbd3 and Brg1 
exhibit direct opposing effects on RNA Polymerase II recruitment and gene 
expression at several hundred genes. Together, our data support the idea that 
chromatin regulatory factors with opposing functions maintain a transcriptionally 
permissive state of pluripotent chromatin while keeping expression levels of 
target genes in control. 
Genome wide Mbd3 localization requires both Brg1 and Tet1 in ES cells 
Despite its methyl binding domain (MBD), Mbd3 is deficient in binding to 
methylated DNA both in vitro and in vivo (Hendrich and Bird, 1998; Saito and 
Ishikawa, 2002) due to the substitution of a phenylalanine for a tyrosine in the 
MBD domain (Saito and Ishikawa, 2002). Intriguingly, this substitution is 
conserved between mouse and human Mbd3 methyl binding domains. Owing to 
this conservation and the phenotypic similarities observed upon depletion of 
Mbd3 and Tet1, the enzyme which hydrolyzes 5mC to 5hmC (Kaji et al., 2006); 
(Koh et al., 2011; Zhu et al., 2009) we hypothesized the potential role of 
hydroxymethylated DNA in Mbd3 recruitment. 
Consistent with this hypothesis, our findings showed similar genome wide 
localization patterns of Mbd3 and Tet1 in ES cells. Both proteins are associated 
with CpG rich Polycomb bound promoters, while the highest Mbd3 enrichment 
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corresponds to genes with high levels of hydroxymethylation (Wu et al., 2011a). 
Moreover, Tet1 depletion causes genome wide Mbd3 de-localization, suggesting 
that hydroxymethylation plays a role in Mbd3 recruitment in vivo. Our in vitro 
findings demonstrated that Mbd3 preferentially binds to 5hmC-containing probes 
relative to 5mC-containing probes. Given the increase in 5mC observed in 
Tet1KD cells at loci that lose 5hmC (Wu et al., 2011a); (Ficz et al., 2011b) and 
our observation that 5mC inhibits Mbd3 binding, we speculate that genomic 
regions with 5mC intermixed with 5hmC might be unfavorable for Mbd3 binding. 
Future studies will dissect the details of how Mbd3/NURD differentially interacts 
with unmodified and hydroxymethylated DNA, and with hemi-modified or 
symmetrically modified DNA.  
Our findings showed that genome wide localization of Mbd3 also requires 
Brg1 in mouse ES cells. It is conceivable, yet highly speculative that Brg1 may be 
functioning upstream of Tet1, facilitating its recruitment to target loci. This 
possibility is particularly intriguing, since our findings showed reduction of bulk 
levels of 5hmC in both Mbd3 and Brg1 depleted cells; that is comparable to Tet1 
depletion in vivo. Further experiments are required to reveal the order of events 
that regulate Mbd3/NuRD recruitment with respect to hydroxymethylcytosine 
function.  
Possible Mechanisms for the role of Mbd3 in the regulation of 5hmC levels 
The reduced levels of hydroxymethylation in Mbd3 knockdowns suggest 
that Mbd3 plays an active role in regulating hydroxymethylation. Several 
possibilities exist that could explain our observations One possibility is that Mbd3 
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could bind to hydroxymethylated DNA and recruit Tet enzymes to hydroxylate 
adjacent methylcytosines. If this is the case Mbd3 depletion should cause an 
increase in 5mC levels similar to Tet1 depletion as it will also cause 
delocalization of Tet1. Another possibility is that Mbd3 could bind to 
hydroxymethylated loci and protect them from further steps in the demethylation 
pathway. If this is the case then Mbd3 depletion should cause an increase in 
unmodified cytosine levels while not affecting the 5mC levels. It is however clear 
that in either case, all three factors Brg1, Mbd3 and Tet1 “collaborate” to maintain 
hmC levels in ES cells. While Brg1 and Tet1 are necessary for Mbd3 localization, 
Mbd3, Brg1 and Tet1 are necessary for normal levels of cytosine 
hydroxymethylation. Although further studies are required to elucidate the 
detailed mechanistic basis for this interdependency, our findings describe Mbd3 
as the first downstream effector that regulates expression of 5hmC-marked 
genes. Data presented in chapter 2 are consistent with a model in which Tet1-
catalyzed hydroxymethylation serves to recruit the Mbd3/NURD complex, and 
thus Mbd3/NURD may be an effector that mediates some of the effects of 
hydroxymethylation on gene expression. Moreover our findings suggest that 
5hmC plays a role in gene regulation beyond serving simply as an intermediate 
in a demethylation pathway. It will be of great interest in future studies to 
determine whether Mbd3 also plays a role in 5hmC biology in other contexts 
such as early embryos (Inoue and Zhang, 2011b; Iqbal et al., 2011), imprinting 
(Reese et al., 2007) or neurons (Kriaucionis and Heintz, 2009). Furthermore, 
dissecting the indispensible role of Mbd3 in embryonic development and 
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differentiation with respect to hydroxylmethylcytosine biology should provide us 
with deeper insights into epigenetic reprogramming.   
H3.3 dynamics confirm conservation of histone turnover in mammals 
Multiple factors and processes including, histone modifications, chromatin 
binding proteins, nucleosome positioning, assembly and remodeling of 
nucleosomes and replacement of canonical histones with histone variants 
contribute to the maintenance and regulation of active chromatin. Activation 
related nucleosome clearance at regulatory DNA elements is a common theme in 
chromatin regulation. A very well known example is facilitation of transcription 
factor binding after eviction of nucleosomes by the activity of ATP dependent 
chromatin remodelers at promoters of transcriptionally active genes. Another 
example is the correlation between DNaseI hypersensitivity sites and active 
regulatory DNA elements (Sabo et al., 2006). Recent studies implicated histone 
turnover as a mechanism to increase DNA accessibility. Genome wide studies in 
yeast and flies revealed unexpected histone replacement activity at regulatory 
regions, such as chromatin boundaries or Polycomb/Trithorax response elements 
(Deal et al., 2010; Dion et al., 2007; Mito et al., 2007). The coincidence of rapid 
histone turnover with specific DNA elements, most notably with promoter regions 
of actively transcribed genes, suggested a role for histone turnover in chromatin 
regulation, as higher histone turnover rates would provide a higher probability of 
DNA element exposure.  
We therefore asked if the conservation of the histone turnover 
phenomenon extends to mammalian genomes. We chose to test this idea in 
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embryonic stem cells to gain more insight into the chromatin dynamics and 
potential role of histone turnover in pluripotent chromatin regulation. Also, 
comparing embryonic stem cell turnover profiles with various differentiated cell 
profiles would enable us to elucidate cell type-specific roles for histone turnover. 
We first focused on dynamics of the well-studied variant H3.3. H3.3 results 
served as proof of principle for our experimental system as our findings were 
consistent with previously published reports in terms of both genome wide 
localization in ES cells (Goldberg et al., 2010) and histone turnover profiles 
observed in flies (Deal et al., 2010; Mito et al., 2007). H3.3 turnover was most 
prominent at genes with high transcriptional activity and more rapid at the +1 
nucleosomes than the -1 nucleosomes, a result that is consistent with the more 
rapid nucleosome replacement downstream of TSS measured by a metabolic 
labeling method in flies (Deal et al., 2010). Moreover our findings also showed 
higher turnover rates at Polycomb occupied genes which are usually targeted to 
CGI promoters in mammalian embryonic stem cells (Mikkelsen et al., 2007). 
Intriguingly, chromatin structure at CGI promoters were shown to be more 
accessible without a requirement for SWI/SNF nucleosome remodeling 
complexes (Ramirez-Carrozzi et al., 2009), suggesting a potential role for histone 
turnover in open chromatin formation at CGI promoters. 
MacroH2A2 localization and dynamics in MEFs and ES cells 
Our tagged MacroH2A2 turnover results revealed three distinct 
populations of MacroH2A containing chromatin that can be distinguished by their 
turnover rates. Two clusters with slow histone dynamics exhibit gradually 
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increasing enrichment of MacroH2A either upstream or downstream of TSS, 
respectively. Another cluster displays very rapid TSS proximal histone 
replacement while the third population shows no histone replacement activity 
even in later time points. Curiously, genes from all four clusters with different 
turnover rates are occupied by endogenous MacroH2A2 in wild type ES cells and 
at different levels in mouse embryonic fibroblasts. Our genome wide localization 
data showed that MacroH2A.2 widely localized to a large number of promoters in 
both pluripotent and differentiated cells, but that it is dynamic at only a subset of 
its binding sites with different turnover rates. These results suggest a potential 
involvement of different chaperone activities for distinct dynamic behaviors of 
MacroH2A2. We are currently investigating the functional consequences of the 
difference in MacroH2A2 dynamics by assaying gene expression defects in 
MacroH2A2 deficient ES cells. It will also be of great interest to see turnover 
rates in inducible MEFs as it will elucidate if there are differences in histone 
dynamic between different cell types with distinct chromatin landscapes. 
Moreover it will provide a better understanding of turnover dynamics of 
MacroH2A2 and their correlation with gene expression (ongoing experiments as 
well). 
Inducible mice as a tool to study chromatin dynamics 
Another exciting property of embryonic stem cells is that they are the cell 
type used to generate transgenic mice as they can contribute to the germline. So 
we took advantage of this developmental potential of embryonic stem cells to 
generate whole animals carrying the tetracycline-inducible epitope-tagged 
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histone variants. These animals have the potential to provide a unique and 
exciting resource for characterization of histone dynamics in different tissues in 
vivo. Moreover as doxycycline can cross the placenta and reach the fetus, these 
animals can be used to study different histone variant dynamics at different 
stages of early development in vivo. 
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